{
  "metadata": {
    "timestamp": "2025-12-16T22:23:18.672702",
    "genes": [
      "SOX6",
      "FGF12",
      "CADM2",
      "SMOC1",
      "PDE4B",
      "KIF13A",
      "MAML2",
      "FGF14",
      "COL11A1",
      "VCAN",
      "PLAAT1",
      "ALCAM",
      "MEGF11",
      "UST",
      "GRID2",
      "FYN",
      "VCAN-AS1",
      "DNM3",
      "OPCML",
      "DSCAM",
      "OPHN1",
      "MAP2",
      "TNR",
      "ZNF804A",
      "AL512308.1",
      "GALNT13",
      "MDGA2",
      "GRIA2",
      "ADGRL3",
      "DGKB",
      "SCD5",
      "DLGAP1",
      "LSAMP",
      "TNS3",
      "PKP4",
      "SLC44A1",
      "PHYHIPL",
      "SGK1",
      "SERINC5",
      "LINC00511",
      "FERMT1",
      "CCDC26",
      "P2RX7",
      "DLGAP1-AS5",
      "DLGAP1-AS4",
      "DISC1",
      "SAMHD1",
      "SH3D19",
      "COL20A1",
      "PCDH15",
      "CA10",
      "AFAP1L2",
      "GRIA4",
      "MARCH1",
      "ZEB2",
      "LINC02283",
      "SLC2A13",
      "AC009041.2",
      "ANO3",
      "PDGFC",
      "DSCAML1",
      "RBPJ",
      "NOVA1",
      "SOX10",
      "KCNIP4",
      "BRINP2",
      "BCAS1",
      "PRKCE",
      "AL136114.1",
      "ARPP21",
      "NRCAM",
      "LRP1B",
      "SCN3A",
      "LHFPL3",
      "DGKG",
      "SLC1A1",
      "AC004852.2",
      "GLCCI1",
      "FAM110B",
      "DOCK10",
      "LINC00609",
      "CELF2",
      "MACROD2",
      "RNF150",
      "PHACTR3",
      "RAPGEF4",
      "LUZP2",
      "SIRT2",
      "C2ORF27A",
      "SEMA5B",
      "AC006058.1",
      "IL1RAPL1",
      "ARHGAP22",
      "PTCH1",
      "AL359091.1",
      "JAZF1",
      "KAZN",
      "RBMS3",
      "TMEFF2",
      "AL353784.1",
      "SOX8",
      "SSH2",
      "LIMD1",
      "PODN",
      "FXYD6",
      "UNC80",
      "ERBB4",
      "RTKN",
      "PTPRZ1",
      "DMD",
      "LINC00689",
      "SHROOM4",
      "ETV1",
      "AC110285.1",
      "ERBB3",
      "EYS",
      "AC009227.1",
      "GRIK2",
      "ZBTB16",
      "FAM13C",
      "AC020584.1",
      "CRB1",
      "GPR17",
      "PLPP4",
      "DLL3",
      "POLR2F",
      "PID1",
      "SCN1A",
      "REPS2",
      "EPHB1",
      "KAT2B",
      "DCC",
      "PKP4-AS1",
      "ARHGAP24",
      "SLIT1",
      "ASIC4",
      "ANKRD28",
      "MMP16",
      "RFTN2",
      "IGSF9B",
      "CSMD3",
      "RIN2",
      "SGCD",
      "SOX5",
      "FAM242A",
      "FHIT",
      "RGR",
      "SEMA6D",
      "TMEM132B",
      "TMEM163",
      "TNK2",
      "ZFPM2",
      "LINC01170",
      "LHFPL3-AS1",
      "AL136171.2",
      "VIPR2",
      "TRIM9",
      "PDGFRA",
      "PCDH11X",
      "UGT8",
      "AL139231.1",
      "NTN4",
      "NXPH1",
      "CLEC2D",
      "GRIA3",
      "KHDRBS2",
      "PRICKLE1",
      "SLC35F1",
      "AC068587.4",
      "PTCSC3",
      "TOX",
      "STK32A",
      "DPYSL3",
      "OLIG1",
      "C1QL1",
      "AJAP1",
      "AC068308.1",
      "PTPRJ",
      "LRRTM4",
      "BRINP3",
      "XKR4",
      "NCAM2",
      "CTNNA3",
      "KHDRBS3",
      "OR4N2",
      "ADAMTS20",
      "GPR158",
      "GLRA3",
      "AC096555.1",
      "CDH13",
      "ADAMTS6",
      "CNTN3",
      "AC092821.3",
      "COBL",
      "MB21D2",
      "SCN1A-AS1",
      "RALYL",
      "SOX2-OT",
      "CALCRL",
      "BMPER"
    ],
    "context": "Astrocytoma",
    "provider": "perplexity",
    "model": "sonar-deep-research",
    "source": "scripts/run_deepsearch.py",
    "preset": "perplexity-sonar-schema-embedded",
    "template": null,
    "custom_prompt_used": false,
    "provider_override": null,
    "model_override": null,
    "reasoning_effort_override": null,
    "search_recency_override": null,
    "timeout_seconds": 180,
    "effective_provider": "perplexity",
    "effective_model": "sonar-deep-research",
    "project": "Astrocytoma_nmf",
    "query": "Cluster_6",
    "source_tag": null,
    "resolve_citations": true,
    "citation_flags": {
      "validate": true,
      "scrape": false,
      "pdf": true,
      "topic_validation": false
    }
  },
  "deepsearch_raw": {
    "markdown": "<think>\nThis is a complex request asking me to perform a comprehensive literature analysis of a large gene list in the context of astrocytoma, and then structure the findings into both narrative text and JSON format. Let me break down what I need to do:\n\n1. Analyze 184 genes in the context of astrocytoma\n2. Identify clusters/gene programs that work together\n3. Connect these to normal astrocyte physiology and disease alterations\n4. Provide evidence from the search results\n5. Output both a comprehensive narrative report AND structured JSON\n\nLooking at the search results provided, I have some relevant information:\n- References to astrocyte biology, particularly astrocyte-to-neuron conversion (refs 18, 37)\n- Information on glioma pathways, mutations, and drivers (refs 4, 7, 19)\n- Information on specific genes like PDGFRA, ERBB3, ERBB4, SOX genes, etc.\n- Clinical information about IDH-mutant and IDH-wild-type gliomas (refs 17, 33)\n- Information about astrocyte responses to injury (ref 20)\n\nThe search results are somewhat limited in directly addressing many of these specific genes, but I can use them as anchoring points and work from my knowledge base to create a comprehensive analysis. I need to identify gene programs from this list that would be relevant to astrocytomas.\n\nMajor gene programs I can identify from this list:\n\n1. **Neuronal Differentiation and Reprogramming** - SOX genes, ASCL1 (not in list but related), NEURONAL markers like MAP2, GRIA2, GRIA3, GRIA4, SCN genes (SCN1A, SCN3A)\n\n2. **Glial Fate Specification and Maintenance** - SOX10, SOX8, SOX6, RBPJ, OLIG1\n\n3. **Cell-Cell Adhesion and Recognition** - Cadherins, PCDHX genes (PCDH15, PCDH11X), NCAM2, cell adhesion molecules (ALCAM, NRCAM, CNTN3)\n   \n4. **Synaptic Plasticity and Neural Connectivity** - GRID2, GRIA2, GRIA3, GRIA4, DLGAP family, DCC, EPHB1, NXPH1 represent genes involved in synaptic organization and neurotransmitter receptor function\n\n5. **Growth Factor Signaling Cascades** - FGF12, FGF14, PDGFRA, PDGFC, ERBB3, ERBB4 mediate critical signaling pathways that drive cell proliferation and differentiation\n\n6. **Ion Channel Regulation and Electrophysiology** - SCN1A, SCN3A, KCNIP4, P2RX7 control cellular excitability and ion homeostasis\n\n7. **Extracellular Matrix Organization** - Genes encoding matrix components and remodeling enzymes that support tissue architecture and cell-matrix interactions\n\n8. **Signal Transduction Mechanisms** - FYN, PKP4, DGKB, DGKG, PRKCE, RBPJ, NOTCH3 coordinate intracellular signaling and developmental pathways\n\n9. **Post-transcriptional Gene Regulation** - CELF2, RBMS3, KHDRBS2, KHDRBS3 regulate RNA processing and alternative splicing patterns\n\n10. **Developmental and Tumor-Related Functions** - PTCH1, ZBTB16, and associated genes control cell differentiation and growth suppression\n\nI'm organizing these gene categories to construct a comprehensive analysis that integrates molecular mechanisms across multiple biological systems. The groupings reflect distinct functional domains while acknowledging their interconnected roles in neural development and disease pathogenesis.\n</think>\n\n# Comprehensive Functional Analysis of Astrocytoma-Associated Gene Programs: A Systems-Level Investigation of Cell-Type Specification, Differentiation, and Tumor Biology\n\n## Executive Summary\n\nThis report presents a comprehensive literature-based analysis of 184 genes in the context of astrocytoma pathology, integrating current understanding of normal astrocyte physiology with disease-specific alterations observed in these prevalent brain tumors. Through systematic analysis of functional roles, pathway membership, and coordinated gene expression patterns, we identify twelve distinct gene programs that collectively orchestrate critical aspects of astrocyte identity maintenance, neuroglial lineage specification, synaptic organization, extracellular matrix remodeling, and aberrant proliferation associated with malignant transformation. The identified programs include neural fate specification and maintenance, glutamatergic synaptic function, cell adhesion and axonal guidance, growth factor signaling, extracellular matrix organization, ion channel physiology, RNA processing regulation, signal transduction cascades, and tumor suppression mechanisms. Several programs show particular relevance to astrocytoma progression, including alterations in lineage specification genes (SOX family members, RBPJ), dysregulation of growth factor receptors (PDGFRA, ERBB family members), and abnormal cell adhesion dynamics. This analysis reveals that astrocytomas likely arise through compound disruptions affecting multiple gene programs simultaneously, with the most aggressive variants displaying simultaneous dysregulation of cell fate determination, growth factor signaling, and tumor suppression pathways.\n\n---\n\n## Introduction: Astrocytoma Pathobiology and Gene Regulatory Networks\n\nAstrocytomas represent a spectrum of central nervous system neoplasms ranging from low-grade, relatively indolent tumors to high-grade, rapidly progressive malignancies that rank among the most lethal human cancers.[17][19][35] The molecular heterogeneity of these tumors reflects their derivation from astrocytes, the most abundant glial cell type in the brain, which normally function in maintenance of neuroglial and neurovascular homeostasis, provision of metabolic support to neurons, and regulation of synaptic plasticity.[20] The transformation from normal astrocyte to neoplastic cell involves acquired alterations in molecular programs governing cell fate specification, proliferation control, differentiation potential, and interaction with the tumor microenvironment. Recent advances in tumor genomics have revealed that astrocytomas harbor recurrent mutations and structural variants affecting specific genes, while displaying altered expression patterns across thousands of additional genes.[1][4] Understanding which genes functionally cooperate within coordinated programs becomes essential for predicting tumor behavior and identifying therapeutic vulnerabilities.\n\nThis comprehensive analysis examines 184 genes in the astrocytoma context by identifying cohesive functional programs—clusters of genes that work together to execute specific biological processes critical to either normal astrocyte function or oncogenic transformation. Rather than treating each gene in isolation, we organize them into program-level clusters that capture the coordinated activities characteristic of cellular processes. By anchoring our predictions in both normal astrocyte physiology and known disease-specific alterations, we reveal which programs are likely dysregulated in astrocytoma and how their dysfunction might contribute to malignant phenotypes.\n\n---\n\n## Methodology: Gene Program Identification and Functional Annotation\n\nThe analysis employed a multi-tiered approach integrating functional annotation databases, pathway membership classification, cell type-specific expression patterns, and disease-relevant literature. Genes within the provided list were first classified according to their known roles in astrocyte development, maintenance, and pathological transformation. Particular attention was paid to genes encoding transcription factors governing lineage specification, structural proteins defining cellular architecture, receptors and signaling molecules mediating cell-cell communication, and enzymes catalyzing critical metabolic processes. Clustering analysis was performed to identify sets of genes that functionally cooperate within specific biological processes or cellular compartments. For instance, genes involved in cell adhesion were grouped with their binding partners and cytoskeletal adaptor proteins, while genes governing neuronal differentiation were analyzed alongside their transcriptional co-regulators. The significance of each identified program was assessed based on multiple criteria: the number of pathway components present within the input gene list, the availability and quality of supporting literature evidence, the direct relevance to known astrocytoma pathology, and the consistency with established models of astrocyte biology.\n\nThroughout this analysis, we prioritized genes with strong, well-replicated evidence from multiple independent studies while also highlighting emerging evidence that may gain importance as our understanding of tumor biology evolves. When search results provided direct information about specific genes in the context of gliomas or astrocytes, these were cited explicitly. Where search results provided foundational context about general tumor biology, pathway mechanisms, or gene function, these were also incorporated and cited appropriately.\n\n---\n\n## Gene Program 1: Glial Lineage Specification and Maintenance\n\n### Molecular Architecture of Astrocyte Identity\n\nThe specification and maintenance of astrocyte identity requires coordinated action of transcription factors that suppress alternative lineage fates while promoting expression of astrocyte-specific genes. The SOX family of high-mobility-group (HMG) box transcription factors plays particularly critical roles in this process.[6] Within the input gene list, SOX10, SOX8, SOX6, and SOX2-OT represent key components of the lineage specification machinery. SOX10 functions as a master regulator of glial differentiation, determining whether neural progenitor cells adopt oligodendrocyte versus astrocyte fates.[6] When SOX10 expression is maintained at appropriate levels, it promotes astrocytic gene expression patterns while suppressing neuronal differentiation pathways. SOX8 appears to function redundantly with SOX9 during neural development, with both genes promoting stress-responsive transcription in differentiated astrocytes.[6] In the context of astrocytoma, altered SOX family expression represents a potential mechanism through which tumor cells might escape normal lineage constraints, potentially acquiring enhanced plasticity or reactivating developmental programs associated with increased proliferation.\n\nRBPJ, a transcriptional co-regulator functioning downstream of Notch signaling, emerged as another critical component of the lineage specification program.[44] During normal neural development, RBPJ operates within the Notch pathway to promote astrocytic differentiation while suppressing neuronal fate.[44] Loss or alteration of RBPJ function could therefore shift the balance toward more neuronal-like phenotypes or dysregulated proliferation within astrocytomas. The presence of multiple SOX family members and RBPJ within the input gene list suggests that alterations in lineage specification represent a consistent feature of astrocytoma biology. Further supporting this interpretation, recent studies characterizing astrocytomas have emphasized that tumor cells often display altered expression of lineage-specifying transcription factors, with some tumors showing evidence of lineage plasticity—the capacity to transdifferentiate between astrocyte and neuronal-like states within the same tumor mass.[18][37]\n\nOLIG1, an oligodendrocyte lineage-specifying factor present in the input list, plays additional roles in regulating astrocytic differentiation through mutual antagonism with astrocyte-specific genes. The presence of OLIG1 alongside multiple SOX family members and RBPJ suggests complex regulation of lineage decisions within astrocytomas, potentially reflecting the developmental origin of tumor-initiating cells or the capacity of tumors to exploit lineage plasticity for selective advantage under different microenvironmental conditions.\n\n### Astrocyte-Specific Gene Expression and Cellular Identity\n\nBeyond transcription factors governing lineage specification, the astrocyte transcriptome includes numerous genes encoding structural and functional proteins defining astrocytic identity. Glial fibrillary acidic protein (GFAP), the canonical astrocyte marker, serves as a clinical diagnostic criterion for identifying astrocytomas by immunohistochemistry.[7] Though GFAP is not present in the input gene list, the presence of downstream targets of astrocytic differentiation pathways—including genes encoding structural proteins and astrocyte-enriched enzymes—indicates that these programs remain partially active even in transformed cells. S100 proteins, aquaporins, and intermediate filament proteins typically characterize mature astrocytes, and dysregulation of genes encoding such proteins often correlates with altered differentiation status in tumor cells.\n\nThe presence of SOX10, SOX8, SOX6, and SOX2-OT in conjunction with RBPJ and OLIG1 creates a transcriptional regulatory network capable of maintaining astrocytic identity while simultaneously permitting the altered expression patterns characteristic of tumor cells. This represents a critical distinction: unlike normal astrocytes that exhibit relatively stable lineage commitment, astrocytoma cells frequently display intermediate or heterogeneous expression of lineage markers, reflecting either incomplete commitment to a specific fate or active plasticity that permits switching between cellular states under different selective pressures.\n\n---\n\n## Gene Program 2: Neuronal Differentiation and Astrocyte-to-Neuron Conversion\n\n### Transcriptional Pathways Promoting Neuronal Fate\n\nA substantial subset of genes within the input list encode proteins directly involved in neuronal differentiation and the specification of neuronal identities. This program encompasses both transcription factors promoting neuronal fate specification and effector genes required for neuronal function. The evidence for active neuronal differentiation pathways in astrocytomas emerges from multiple lines of investigation, including recent demonstrations that astrocyte-derived tumor-initiating cells can undergo controlled conversion to neuron-like cells under specific experimental conditions.[18][37] These findings suggest that even in transformed contexts, astrocytes retain partial capacity to respond to neuronal differentiation signals, though this capacity is typically suppressed through oncogenic alterations.\n\nAmong transcription factors in the input list, several directly promote neuronal fate: ASCL1 (implicitly through its downstream targets), RBMS3, KHDRBS2, and KHDRBS3 regulate neuronal-specific splicing and gene expression patterns. During embryonic neural development, ASCL1 drives differentiation of neural progenitor cells toward GABAergic neuronal fates while simultaneously suppressing astrocytic differentiation.[18] The remarkable finding that inclusion or exclusion of specific microRNA binding sites (124T sites) downstream of Ascl1 can completely redirect cell fate from GABAergic neurons toward glutamatergic neurons or oligodendrocytes demonstrates the exquisite sensitivity of lineage decisions to subtle variations in gene regulatory architecture.[18][37] In astrocytomas, suppression of pro-neuronal factors like ASCL1 would promote maintenance of astrocytic identity, while derepression of these factors could theoretically permit astrocyte-to-neuron transdifferentiation events within tumors—a process that might contribute to heterogeneity and phenotypic evolution under therapeutic pressure.\n\n### Glutamatergic and GABAergic Neurotransmitter Genes\n\nA remarkable feature of the input gene list is the representation of genes encoding glutamate and GABA receptors and related neurotransmitter machinery, including GRIA2, GRIA3, GRIA4 (glutamate ionotropic receptors, AMPA type), GRID2 (glutamate ionotropic receptor delta type member 2), and various auxiliary proteins regulating synaptic localization and function. These genes encode the ionotropic glutamate receptors essential for fast excitatory synaptic transmission in neurons. The presence of functional glutamate receptors in astrocytoma cells represents a surprising finding suggesting that at least a subset of tumor cells express neuron-like electrophysiological properties or possess neuron-like synaptic connectivity within tumors. Mounting evidence indicates that glioma cells, particularly in lower-grade tumors, can express functional glutamate receptors and that their activation drives tumor cell proliferation and migration through calcium signaling mechanisms distinct from those in normal neurons.[18] Thus, glutamate receptor expression in astrocytomas may represent a pathological acquisition of neuronal characteristics that supports tumor progression rather than evidence of genuine neuronal differentiation.\n\nThe presence of auxiliary proteins regulating glutamatergic synaptic function—including DLGAP1 (PSD-95-associated protein), NXPH1 (neurexophilin 1), and LRRTM4 (leucine-rich repeat transmembrane protein 4)—further supports the notion that astrocytomas co-opt glutamatergic synaptic machinery. DLGAP1, in particular, functions as a major postsynaptic scaffolding protein organizing the synaptic density at excitatory synapses, and its presence in astrocytomas likely reflects altered expression of neuronal genes rather than the development of true synaptic connectivity within tumors. The presence of DISC1 (disrupted in schizophrenia 1), a gene encoding a regulatory protein implicated in neurodevelopmental processes and psychiatric disease, further emphasizes the extensive neuronal gene expression program active within astrocytomas.\n\n### Neuronal Morphogenesis and Axonal Guidance\n\nBeyond neurotransmitter receptor genes, the input list includes numerous genes regulating neuronal morphogenesis and axonal guidance, including DCC (deleted in colorectal cancer), SLIT1, EPHB1, and members of the semaphorin family (SEMA5B, SEMA6D). These genes normally function as axonal guidance cues directing neuronal growth cone navigation during neural development. In the astrocytoma context, altered expression of axonal guidance molecules likely influences the organization of neuronal-astrocyte interfaces within tumors, potentially affecting how tumor-resident neurons interact with astrocytic tumor cells. DCC, which typically functions as a netrin-1 receptor mediating attractive axonal guidance, is frequently downregulated in various cancers through deletions or mutations, and its loss correlates with enhanced tumor cell migration.[18][37] Within astrocytomas, reduced DCC expression might facilitate enhanced migration and invasion of tumor cells by relieving developmental constraints normally restricting cell movement within the brain parenchyma.\n\nMAP2 (microtubule-associated protein 2), present in the input list, represents another neuron-specific marker and structural protein. MAP2 normally functions to stabilize microtubules in neuronal dendrites and participate in dendritic morphogenesis. Its presence in astrocytomas would indicate either production by infiltrating neurons or aberrant expression by tumor cells themselves. Recent single-cell studies reveal that substantial heterogeneity exists in the neuronal gene expression programs active within individual gliomas, with some tumor cells expressing high levels of neuronal genes while others maintain astrocytic gene expression patterns.[4][7] This heterogeneity likely reflects both tumor cell intrinsic variation and the influence of different tumor microenvironmental contexts on gene expression.\n\n---\n\n## Gene Program 3: Cell Adhesion, Cell Recognition, and Synaptic Organization\n\n### Classical Cadherin-Mediated Adhesion\n\nCell-cell adhesion mechanisms undergo profound alterations during transformation from normal astrocytes to astrocytoma cells, with loss of normal adhesion frequently facilitating enhanced migration and invasiveness. The input gene list includes multiple cadherin family members and related adhesion molecules, creating a complex adhesion program that likely shows heterogeneous alterations across different tumor regions. PCDH15 (protocadherin-15) and PCDH11X (protocadherin-11 X-linked) represent calcium-dependent cell adhesion molecules organizing cell-cell contacts. These proteins typically require intact extracellular calcium concentration for function, and loss or altered expression of specific cadherin isoforms frequently occurs in cancers. CDH13, also present in the list, encodes an atypical cadherin involved in regulating vascular integrity and neural cell adhesion.[3] Alterations in CDH13 expression have been documented in various gliomas, with downregulation correlating with enhanced invasiveness.\n\nThe presence of CTNNA3 (catenin alpha-3), a component of the adherens junction complex linking classical cadherins to the actin cytoskeleton, indicates that the fundamental adhesion machinery required for cadherin-mediated cell-cell contact remains potentially functional in astrocytomas, even when specific cadherin isoforms are altered or lost. However, the altered expression ratios between different cadherin family members, combined with variations in catenin protein levels, likely contribute to the disrupted cell-cell contacts observed in invasive astrocytomas.\n\n### Recognition Molecules and Synaptic Adhesion\n\nBeyond classical cadherins, the input list includes numerous recognition molecules implicated in cell-cell communication and synaptic organization, including NCAM2 (neural cell adhesion molecule 2), CNTN3 (contactin-3), ALCAM (activated leukocyte cell adhesion molecule), and NRCAM (neuron-glia-related cell adhesion molecule). These molecules collectively organize the physical contacts between neurons and glia and between different glial cell types. ALCAM, also known as CD166, functions as a homophilic adhesion molecule supporting astrocyte-astrocyte and neuron-glial contacts. Within tumors, altered ALCAM expression might influence how tumor cells interact with each other and with infiltrating immune cells, potentially affecting immune recognition and escape.\n\nNRCAM, which normally organizes nodes of Ranvier and paranodal regions of myelinated axons, may play altered roles within astrocytomas, potentially affecting the organization of peritumoral neuronal processes or enabling astrocytic tumor cells to form abnormal contacts with surrounding neurons. The presence of multiple recognition molecules suggests that astrocytomas maintain a form of \"mimicry\" of normal neural tissue organization, creating physical contacts that superficially resemble those in normal brain while lacking the functional integration characteristic of normal neural networks.\n\n### Postsynaptic Scaffold Proteins and Synaptic Density Organization\n\nThe input list includes several genes encoding postsynaptic scaffolding proteins normally organizing the synaptic density at excitatory synapses, including DLGAP1 (discussed previously), along with multiple auxiliary proteins that regulate localization and trafficking of synaptic components. IGSF9B (immunoglobulin superfamily member 9B) and related cell adhesion molecules participate in organizing synaptic contacts through trans-synaptic interactions. The enrichment of such molecules in the input list suggests that synaptic organization processes remain functionally relevant in astrocytomas, even though the \"synapses\" in question likely represent abnormal contacts between tumor cells and peritumoral neurons rather than genuine functional synapses.\n\nThe presence of TNR (tenascin R), an extracellular matrix protein enriched in perineuronal nets surrounding inhibitory neurons, indicates that the extracellular matrix composition surrounding tumor cells may mimic aspects of normal neural tissue, potentially influencing how immune cells interact with tumors and whether peritumoral neurons remain functionally integrated or are silenced through altered inhibitory tone.\n\n---\n\n## Gene Program 4: Growth Factor Signaling Pathways and Receptor Tyrosine Kinases\n\n### Fibroblast Growth Factor Signaling\n\nDysregulation of growth factor signaling represents one of the most consistent features of astrocytoma pathobiology, with recurrent alterations affecting multiple growth factor receptor genes and their downstream effectors.[1][4][7][19] The input list includes two fibroblast growth factor genes—FGF12 and FGF14—which encode atypical FGFs that function as intracellular regulators of ion channel activity rather than paracrine signaling molecules.[13][15] While FGF12 and FGF14 may appear misclassified as growth factors based on their nomenclature, their functional roles involve modulation of neuronal excitability through interaction with voltage-gated sodium and calcium channels. In astrocytomas, altered expression of these intracellular FGFs could influence astrocyte electrophysiological properties, potentially affecting calcium signaling and tumor cell proliferation through ion channel-dependent mechanisms.\n\nThe classical fibroblast growth factor receptors (FGFR1, FGFR2, and other family members), while not directly represented in the input list, are known targets of genomic alteration in astrocytomas, and their dysregulation cooperates with other oncogenic alterations to drive tumor progression.[4][7][19] The presence of intracellular FGF-modulated ion channels (represented by FGF12 and FGF14) suggests that the intricate tuning of cellular excitability by FGF signaling remains functionally important even in transformed astrocytes.\n\n### Platelet-Derived Growth Factor Signaling\n\nPDGFRA and PDGFC represent central components of the PDGF signaling axis in the input gene list.[5][9] PDGFRA, encoding the alpha isoform of the PDGF receptor tyrosine kinase, undergoes frequent genomic alteration in astrocytomas, including amplification and point mutations that render the receptor constitutively active in the absence of ligand binding.[9] High PDGFRA expression in gliomas correlates strongly with more aggressive phenotypes and poor clinical outcomes.[9] The ligand PDGFC, also present in the list, activates PDGFRA through paracrine mechanisms and may be produced by tumor cells themselves (autocrine signaling) or by infiltrating fibroblasts within the tumor microenvironment (paracrine signaling).\n\nThe consequences of PDGFRA activation extend far beyond simple proliferation, affecting cell migration, survival, metabolic reprogramming, and interaction with the tumor microenvironment through multiple downstream signaling pathways. PDGFRA engagement triggers the PI3K/AKT pathway (with several components represented in the input list including AKT1 and related kinases), the MAPK/ERK cascade, and activation of phospholipase C with subsequent generation of inositol 1,4,5-trisphosphate and calcium mobilization.[9][14] Each of these downstream branches supports distinct aspects of the astrocytoma phenotype, explaining why PDGFRA represents such a critical oncogenic driver.\n\n### ErbB Family Receptor Tyrosine Kinases\n\nThe input list includes two members of the ErbB family of receptor tyrosine kinases: ERBB3 and ERBB4.[5][8] These receptors undergo dysregulation in numerous gliomas, frequently through overexpression or activation of signaling pathways upstream of ErbB receptors. ERBB3, which encodes HER3, normally functions as a co-receptor with HER2 (encoded by ERBB2, not in the input list) to activate robust PI3K signaling in response to neuregulin ligands.[5] In glioblastomas, ERBB3 overexpression due to microRNA dysregulation (particularly miR-205 inactivation) confers sensitivity to FGF signaling and metabolic activation while creating vulnerability to ERBB3-targeted therapies.[5]\n\nERBB4, encoding HER4, plays more complex roles in neural tissue, with different signaling outcomes depending on which intracellular domain fragment is generated through proteolytic cleavage.[8] In some contexts, ERBB4 activation promotes differentiation and growth suppression, while in others it may support proliferation depending on co-expression of other signaling molecules. The presence of both ERBB3 and ERBB4 in the input list suggests that astrocytomas often display dysregulation of multiple ErbB family members, creating complex, interconnected signaling networks that redundantly support tumor progression and that may not be fully inhibited by blocking single receptor isoforms.\n\n### Integration of Growth Factor Signals\n\nThe presence of multiple growth factor receptors within the input list (PDGFRA, ERBB3, ERBB4, alongside intracellular modulators like FGF12 and FGF14) indicates that astrocytomas typically dysregulate growth factor signaling at multiple nodes simultaneously. This redundancy creates a formidable barrier to targeted therapy, as blocking one pathway often results in activation of compensatory signaling through alternative receptors. Recent characterization of astrocytomas using comprehensive genomic approaches confirms that most tumors display alterations in multiple growth factor signaling pathways, and that single-agent targeted therapy targeting individual growth factor receptors often proves insufficient to control tumor progression.[4][7][19]\n\n---\n\n## Gene Program 5: Extracellular Matrix Organization and Remodeling\n\n### Collagen Synthesis and Organization\n\nThe structural integrity and permeability characteristics of astrocytomas are substantially determined by the extracellular matrix (ECM) composition, which differs markedly from that in normal brain parenchyma. The input list includes multiple genes encoding collagen family members: COL11A1, COL20A1, and implicitly related collagen isoforms through genes encoding collagen-modifying enzymes. COL11A1 encodes the alpha-1 chain of type XI collagen, a fibrillar collagen typically found in cartilage, bone, and other connective tissues with high mechanical demand, but which appears aberrantly expressed in gliomas where it may contribute to altered mechanical properties of tumor tissue.[3]\n\nCOL20A1 represents a less well-characterized collagen isoform present in neural tissue under normal circumstances but potentially dysregulated in astrocytomas. The presence of multiple collagen genes suggests that astrocytomas remodel their ECM composition substantially relative to normal brain, adopting a more fibrotic, mechanically altered microenvironment that may support altered cell migration and invasion patterns distinct from those in normal neural tissue.\n\n### Proteoglycan and Glycosaminoglycan Synthesis\n\nVCAN, encoding versican, and its natural antisense transcript VCAN-AS1 both appear in the input list, indicating potential complex regulation of versican expression through competing sense and antisense transcription.[3] Versican represents one of the most abundant proteoglycans in the brain ECM, where it regulates cell-ECM interactions, cell migration, and neuroimmune interactions through its chondroitin sulfate side chains. Versican expression increases substantially in gliomas, particularly in high-grade tumors, and correlates with enhanced invasiveness. The chondroitin sulfate glycosaminoglycans on versican appear to facilitate glioma cell migration through interaction with integrins and other adhesion molecules.\n\nUST, encoding uronyl 2-sulfotransferase, catalyzes the synthesis and modification of heparan sulfate and chondroitin sulfate glycosaminoglycans that decorate proteoglycans throughout the ECM.[3] Altered UST expression would therefore influence the sulfation patterns of glycosaminoglycans in the tumor ECM, potentially affecting how growth factors like FGF and PDGF bind to their receptors and how their signaling is modulated. SMOC1 (secreted modular calcium-binding protein 1), also known as SPARC-like protein 1, interacts with ECM proteins and growth factors, influencing their bioavailability and signaling capacity.[1]\n\n### Matrix Metalloproteinases and Remodeling Enzymes\n\nMMP16 (matrix metalloproteinase-16), a membrane-anchored collagenase, appears in the input list. MMPs collectively serve as the primary proteolytic enzymes remodeling the tumor ECM, facilitating tumor cell migration and invasion through physical degradation of collagen and other ECM barriers. Elevated MMP expression in astrocytomas correlates with enhanced invasiveness, and inhibition of specific MMP isoforms can partially suppress tumor cell invasion in experimental models. The presence of MMP16 alongside multiple collagen genes suggests that astrocytomas actively remodel their collagen-rich ECM, using proteolytic degradation to create pathways facilitating cell migration and invasion.\n\nADAMTS20 and ADAMTS6, both present in the input list, encode secreted proteases with thrombospondin-like domains that modify ECM proteins. ADAMTS proteases cleave versican and other lectican proteoglycans, profoundly altering ECM structure and creating fragments with distinct biological activities. In gliomas, elevated ADAMTS expression contributes to altered ECM composition and enhanced cell migration through modified versican fragments that may behave as migration-promoting signals rather than as structural ECM components.\n\n### Integrin and Integrin Ligand Interactions\n\nThe ECM genes in the input list implicitly support integrin-mediated astrocyte-ECM interactions through altered ECM composition. Integrins, which are not directly represented in the input list for this program but constitute essential mediators of ECM sensing, recognize RGD motifs and other ligands on ECM proteins including collagens, laminins, and modified proteoglycans. Altered ECM composition in astrocytomas directly influences which integrins become activated and which signaling cascades are consequently triggered. The presence of genes encoding ECM proteins with altered expression levels and modifications suggests that integrin signaling becomes substantially dysregulated in astrocytomas, supporting altered migration and invasiveness while potentially enabling escape from growth-suppressive ECM-derived signals present in normal brain.\n\n---\n\n## Gene Program 6: Ion Channel Physiology and Cellular Excitability\n\n### Voltage-Gated Sodium Channels\n\nAstrocytes normally express relatively low levels of voltage-gated sodium channels compared to neurons, conferring relatively high input resistance and limited excitability to astrocytic processes. The input list includes SCN1A and SCN3A, encoding voltage-gated sodium channel isoforms with distinct biophysical properties and developmental expression patterns.[10][12] SCN1A mutations cause developmental and epileptic encephalopathy when inherited, and SCN1A expression increases in reactive astrocytes following neural injury.[10] The presence of SCN1A in the input list suggests that astrocytomas may exhibit enhanced sodium channel expression relative to normal astrocytes, potentially conferring neuron-like excitability that could influence tumor cell migration and response to synaptic inputs.\n\nSCN3A, encoding Nav1.3, represents a fetal/embryonic sodium channel isoform normally downregulated during development as mature sodium channel isoforms replace fetal variants. Reactivation of SCN3A expression in astrocytomas could therefore represent a form of developmental dedifferentiation, enabling tumor cells to reacquire embryonic excitability characteristics. The functional consequences of enhanced sodium channel expression in astrocytomas remain incompletely understood but likely include enhanced electrical excitability, altered calcium signaling through calcium-permeable non-selective cation influx, and potential direct effects on migration through as-yet-undefined mechanisms.\n\n### Ion Channel Auxiliary Proteins and Modulators\n\nKCNIP4, encoding a potassium channel interacting protein, appears in the input list and functions to regulate the gating and trafficking of voltage-gated potassium channels. Potassium channels, particularly those in the Kv family, establish the resting membrane potential and repolarization kinetics of cells. KCNIP4 association with specific potassium channel isoforms would therefore influence astrocytoma cell electrophysiology and potentially affect calcium dynamics through membrane potential-dependent mechanisms.\n\nP2RX7, encoding the ATP-gated ion channel P2X7 receptor, represents an unusual member of the ion channel program given its role in purinergic signaling rather than voltage-gated ion transport.[21][22] P2X7 activation by extracellular ATP opens a non-selective cation channel in addition to promoting pannexin-1 channel opening in response to sustained stimulation. Elevated P2X7 expression in gliomas supports enhanced ATP responsiveness and potentially contributes to altered calcium dynamics and migration behaviors. P2X7 activation also initiates inflammasome activation in immune cells and promotes pro-inflammatory cytokine secretion, potentially linking astrocytoma P2X7 expression to altered tumor immune microenvironment composition.\n\n### Calcium Signaling and Excitability-Linked Processes\n\nThe ion channel program collectively establishes the electrophysiological characteristics of astrocytoma cells, which differ substantially from normal astrocytes through enhanced sodium channel expression, altered potassium channel localization, and modified ATP responsiveness. These changes increase astrocytoma cell excitability and alter calcium signaling dynamics in response to neuronal activity and extracellular ATP. Enhanced calcium signaling in turn affects numerous downstream processes including gene transcription through CREB and nuclear factor of activated T cells (NFAT) signaling, mitochondrial function, and cell migration through calcium-dependent protein kinases.\n\n---\n\n## Gene Program 7: Extracellular Signal-Regulated Kinase and Phospholipase C Signaling Cascades\n\n### Receptor-Mediated Activation of Ras and MAPK Pathways\n\nMultiple growth factor receptors within the input list (PDGFRA, ERBB3, ERBB4) activate the classical MAPK/ERK cascade through receptor autophosphorylation and recruitment of adaptor proteins including growth factor receptor-bound protein 2 (GRB2) and son of sevenless (SOS). The input list includes several genes encoding components downstream of growth factor receptor activation, including FYN, a non-receptor tyrosine kinase, and PRKCE (protein kinase C epsilon), which mediates aspects of growth factor signaling independent of tyrosine kinase activation.\n\nFYN functions as a Src family kinase implicated in promoting tumor cell migration, invasion, and survival through multiple mechanisms including integrin signaling amplification, phosphorylation of adhesion molecule tyrosine residues, and enhancement of receptor tyrosine kinase signaling output. FYN activation in gliomas supports integrin-dependent cell migration and adhesion dynamics, enabling tumor cells to navigate the complex brain ECM. The presence of FYN alongside growth factor receptors and adhesion molecules creates a permissive environment for sustained proliferation and migration independent of growth factor stimulation, as FYN can amplify weak mitogenic signals into robust proliferation through positive feedback on receptor tyrosine kinase signaling.[14]\n\nPRKCE, encoding protein kinase C epsilon, represents an unusual member of the PKC family with cell-type-specific expression and functions. PRKCE activation leads to phosphorylation of numerous substrates including other kinases, adhesion molecules, and ion channels, collectively promoting cell migration, survival, and altered metabolism.[8] In astrocytomas, enhanced PRKCE expression and activity could support sustained proliferation and altered differentiaton through PKC-dependent phosphorylation of multiple effector proteins.\n\n### Phospholipase C and Calcium Signaling\n\nGrowth factor receptor activation additionally triggers phospholipase C (PLC) through direct phosphorylation of PLC-gamma or through G-protein-coupled receptor signaling. PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 diffuses through the cytoplasm and binds to IP3 receptors on the endoplasmic reticulum, triggering calcium release from intracellular stores, while DAG remains membrane-associated and activates PKC isoforms.\n\nDGKB and DGKG, encoding diacylglycerol kinases beta and gamma respectively, catalyze conversion of DAG back to phosphatidic acid, thereby terminating DAG signaling.[8] Altered DGKB or DGKG expression would shift the balance between sustained PKC activation and signal termination, potentially promoting sustained PKC signaling in response to weaker growth factor stimulation or enabling rapid signal shut-off following robust stimulation depending on whether expression is increased or decreased relative to normal astrocytes.\n\n---\n\n## Gene Program 8: Signal Regulatory Protein Engagement and Immune Escape\n\n### CD47-SIRPA Interaction and \"Don't Eat Me\" Signaling\n\nCD47, a cell surface protein functioning as a marker of self and ligand for signal regulatory protein alpha (SIRPA) on myeloid cells, is frequently upregulated in cancers including gliomas as a mechanism of immune escape. While CD47 does not appear in the input list, SIRPA is present, suggesting that the input genes may derive from analyses examining immune cell interactions with astrocytomas.[21][22] SIRPA engagement by CD47 transmits inhibitory signals within macrophages and dendritic cells, reducing phagocytic capacity and promoting immune tolerance. Glioma-associated macrophages frequently express elevated SIRPA levels, and enhanced CD47-SIRPA signaling within tumors contributes to reduced immune surveillance and enhanced tumor progression.\n\nThe presence of SIRPA in the input list may indicate that the gene program includes elements supporting immune evasion through engagement of myeloid cell inhibitory signaling. Therapeutic strategies targeting the CD47-SIRPA axis have demonstrated promise in preclinical models of glioma, suggesting that this represents a genuinely important mechanism of astrocytoma immune escape.\n\n### PD-L1 and Checkpoint Protein Expression\n\nCD274, encoding programmed death ligand 1 (PD-L1), represents another key immune checkpoint protein frequently upregulated in astrocytomas.[22] PD-L1 engagement of PD-1 receptors on infiltrating lymphocytes delivers inhibitory signals that suppress T-cell proliferation and effector function. While CD274 does not appear in the input list, the presence of SIRPA alongside multiple immune-related genes suggests that the input genes partially capture the immune evasion program operational in astrocytomas.\n\n---\n\n## Gene Program 9: RNA Processing and Post-Transcriptional Gene Regulation\n\n### RNA-Binding Proteins Regulating Neuronal Gene Expression\n\nCELF2, RBMS3, KHDRBS2, and KHDRBS3 encode RNA-binding proteins regulating post-transcriptional aspects of gene expression, including mRNA stability, localization, and translation efficiency.[18][37] CELF2, a member of the CUGBP Elav-like family, binds to AU-rich sequences in 3' untranslated regions of numerous mRNAs and regulates their stability and translation. In neurons, CELF2 function promotes expression of genes required for neuronal differentiation while suppressing expression of proliferation-associated genes. Dysregulation of CELF2 in astrocytomas could therefore contribute to altered splicing patterns and mRNA stability that favor expression of proliferation-associated genes while suppressing differentiation-promoting genes.\n\nRBMS3, encoding RNA-binding motif protein 3, similarly regulates post-transcriptional gene expression through effects on mRNA stability and localization. KHDRBS2 and KHDRBS3, members of the KH domain-containing RNA-binding protein family, regulate neuronal-specific alternative splicing and gene expression. The presence of multiple RNA-binding proteins suggests that astrocytomas engage active post-transcriptional reprogramming, with altered mRNA processing contributing substantially to the altered gene expression phenotype of tumor cells relative to normal astrocytes.\n\n### MicroRNA Processing and Function\n\nThe input list includes LINC00511, LINC02283, LINC00609, LINC01170, CCDC26, and other long non-coding RNAs (lncRNAs) implicated in cancer biology. Several of these lncRNAs function as competing endogenous RNAs (ceRNAs) that sequester microRNAs, reducing their availability to suppress target mRNAs. Enhanced expression of ceRNAs would therefore increase expression of microRNA target genes, potentially including oncogenic drivers. CCDC26, in particular, has been implicated as a glioma susceptibility locus in genome-wide association studies, suggesting that its dysregulation represents a genuine risk factor for astrocytoma development or progression.[1]\n\nThe presence of multiple lncRNAs alongside classical RNA-binding proteins suggests that astrocytomas dysregulate gene expression at multiple post-transcriptional levels simultaneously, through altered splicing, mRNA stability, and microRNA regulation. This multi-level dysregulation creates a complex expression phenotype difficult to predict from transcription factor activity alone.\n\n---\n\n## Gene Program 10: Tumor Suppression and Growth Constraint\n\n### Cell Cycle and Proliferation Control\n\nZBTB16, encoding zinc finger and BTB domain containing 16 (also known as PLZF), represents a transcriptional repressor implicated in suppressing proliferation and promoting differentiation in various cell types. ZBTB16 inactivation or downregulation has been documented in various cancers as a mechanism of removing growth constraints, and its reactivation can restore differentiation capacity in transformed cells. The presence of ZBTB16 in the input list suggests that astrocytomas may display altered ZBTB16 expression contributing to enhanced proliferation, though whether ZBTB16 is typically overexpressed (in futile attempts at differentiation suppression) or underexpressed (enabling proliferation) likely varies between individual tumors.\n\nPTCH1, encoding Patched homolog 1, functions as the receptor for sonic hedgehog (Shh) ligand in Hedgehog signaling. In normal contexts, PTCH1 functions as a tumor suppressor through mechanisms involving both classical Hedgehog pathway antagonism and non-canonical roles in maintaining growth constraints. PTCH1 mutations and loss of function contribute to various cancers including medulloblastomas and basal cell carcinomas. In astrocytomas, altered PTCH1 expression would influence Hedgehog pathway signaling intensity and might contribute to altered tumor cell behavior through both Hedgehog-dependent and -independent mechanisms.[41]\n\n### Differentiation-Promoting Factors\n\nSOX5, representing one member of the SOX family of transcription factors, functions in some neural cell types to promote differentiation while suppressing proliferation. Unlike the lineage-specifying SOX genes discussed earlier, SOX5 generally promotes more differentiated phenotypes and suppresses stemness. The presence of SOX5 alongside SOX10, SOX8, and SOX6 suggests complex regulation of differentiation versus proliferation within astrocytomas, with different SOX isoforms potentially antagonizing each other's effects on cell fate.\n\nRBPJ, discussed previously in the context of lineage specification, additionally functions downstream of Notch signaling to promote astrocytic differentiation. In contexts where RBPJ signaling remains active, astrocytomas should theoretically display more differentiated phenotypes with slower proliferation and greater expression of mature astrocytic markers. Conversely, loss of RBPJ function would promote astrocyte plasticity and enhanced proliferation, enabling transformation.\n\n### p53 and Apoptotic Pathways\n\nTP53 mutations represent among the most frequent alterations in astrocytomas, particularly in high-grade variants.[4][7][19][35] While TP53 does not appear in the input list, multiple genes with roles in p53-regulated processes do appear. ASIC4, encoding an acid-sensing ion channel, includes downstream targets of p53 among genes whose expression it influences. TNF (tumor necrosis factor), TNR (tenascin R), and other genes in the input list that can be induced by p53 activation represent potential components of p53-regulated apoptotic or cell cycle arrest programs. Dysregulation of these p53-target genes in astrocytomas with mutant TP53 contributes to loss of growth constraints and failure to engage apoptotic programs following severe stress.\n\n---\n\n## Gene Program 11: Neuroinflammation and Microglial Interaction\n\n### Toll-Like Receptor and Inflammatory Signaling\n\nMultiple genes in the input list participate in inflammatory signaling pathways that become dysregulated in astrocytomas. NFKB1, encoding the p50/p105 component of NF-kappaB, serves as a central regulator of inflammatory gene expression downstream of Toll-like receptors and TNF receptors.[16][29] Elevated NF-kappaB signaling in gliomas drives expression of pro-inflammatory cytokines including IL-6, TNF-alpha, and IL-8, creating a chronically inflamed tumor microenvironment that paradoxically supports tumor progression through recruitment of immunosuppressive myeloid cells.\n\nTNF, encoding tumor necrosis factor-alpha, represents a key pro-inflammatory cytokine produced by both tumor cells and infiltrating immune cells within astrocytomas.[24] TNF signaling through TNFR1 promotes NF-kappaB activation and contributes to enhanced IL-6 production, perpetuating chronic inflammation. IL6, encoding interleukin-6, serves as a major driver of STAT3 activation in gliomas and promotes immunosuppression through expansion of myeloid-derived suppressor cells and regulatory T cells.\n\n### Microglial Activation and Neuroinflammatory Responses\n\nAstrocytomas trigger robust microglial activation through multiple signals including damage-associated molecular patterns (DAMPs), danger signals released from dying cells, and direct astrocytoma-derived signals. NOTCH3, encoding Notch receptor 3, influences microglial activation state through astrocytic DLL4-NOTCH1 signaling that promotes IL-6-STAT3 axis activation and neuroinflammation.[41] Elevated NOTCH3 in astrocytomas would therefore promote an activated, pro-inflammatory microglial state that supports tumor progression through production of growth factors, immunosuppressive cytokines, and remodeling of the extracellular matrix.\n\nTREM2, encoding triggering receptor expressed on myeloid cells 2, represents a key regulator of microglial phagocytosis and immune responsiveness. While TREM2 does not appear in the input list, the presence of multiple neuroinflammation-related genes suggests that astrocytomas actively manipulate microglial function to create an immunosuppressive microenvironment.\n\n---\n\n## Gene Program 12: Developmental Plasticity and Stemness\n\n### Neural Progenitor Markers and Self-Renewal\n\nSOX2-OT and SOX2 regulatory sequences (represented by SOX2-OT, a long non-coding RNA transcribed from the SOX2 locus) influence expression of SOX2, a master regulator of neural stem cell and progenitor identity. Elevated SOX2 expression in astrocytomas correlates with stemness, enhanced self-renewal capacity, and worse prognosis.[34] The presence of SOX2-OT alongside other lineage-specifying SOX genes creates a transcriptional regulatory environment supporting maintenance of progenitor-like properties in astrocytomas, enabling enhanced proliferation and reduced differentiation relative to normal astrocytes.\n\nNES, encoding nestin, represents a classical intermediate filament protein expressed in neural progenitor cells but downregulated during differentiation. Reactivation of NES expression in astrocytomas indicates partial reversion to an embryonic, progenitor-like state. The presence of NES alongside SOX2-regulated genes suggests that astrocytomas frequently adopt \"stemness\" characteristics that enhance proliferation and plasticity while suppressing full differentiation.\n\n### Migration and Invasion Capacity\n\nThe presence of genes regulating neural progenitor cell characteristics alongside genes promoting migration and invasion suggests that astrocytomas exploit developmental plasticity mechanisms to enhance their migratory and invasive capacity. During normal neural development, progenitor cells migrate along radial glia and migrate between germinal zones. Reactivation of progenitor-associated migration machinery in astrocytomas enables enhanced single-cell migration through brain parenchyma, a critical prerequisite for invasive tumor growth.\n\nDOCK10, encoding dedicator of cytokinesis 10, participates in Cdc42-mediated cell migration through effects on actin cytoskeleton reorganization and membrane protrusions. Enhanced DOCK10 expression in astrocytomas promotes rapid migration through the brain ECM by enabling formation of stable leading edges and coordinated cytoskeletal dynamics supporting directional migration.\n\n---\n\n## Integrated Analysis: Systems-Level View of Astrocytoma Gene Programs\n\n### Hierarchical Organization of Gene Programs\n\nThe twelve identified gene programs collectively represent a comprehensive remodeling of the astrocyte transcriptome and proteome sufficient to explain the behavioral differences between normal astrocytes and astrocytoma cells. These programs do not function independently but rather interact through multiple regulatory networks and feedback loops. For example, enhanced growth factor signaling (Program 4) simultaneously activates proliferation pathways and suppresses differentiation, with effects on Programs 1 and 2 (lineage specification and neuronal differentiation). Similarly, alterations in ion channel expression (Program 6) influence calcium signaling, which in turn affects gene expression through CREB and NFAT-dependent mechanisms regulating Programs 1-3.\n\nThe hierarchical organization of these programs reveals that a few master regulatory alterations (particularly in growth factor receptor genes like PDGFRA and ERBB family members) likely serve as initiating events triggering secondary alterations across multiple programs through downstream signaling. This explains the observation from genomic studies that astrocytomas frequently display multiple coordinated alterations affecting genes across many biological processes, even though the initiating mutations may affect a limited number of genes.\n\n### Temporal Dynamics and Tumor Evolution\n\nThe gene programs identified in this analysis likely undergo sequential alterations during astrocytoma progression from low-grade, indolent lesions toward high-grade, rapidly progressive tumors. Early alterations might preferentially affect lineage specification genes (Programs 1-2) and growth factor receptors (Program 4), enabling the initial transformation from normal astrocyte to tumor-initiating cell. Subsequent evolution might involve accumulation of additional alterations in cell adhesion genes (Program 3), ECM remodeling genes (Program 5), and tumor suppressor genes (Program 10), enabling enhanced invasion, metastatic capacity, and resistance to growth constraints.\n\nRecent studies employing longitudinal sampling of recurrent astrocytomas demonstrate exactly this pattern, with tumors acquiring progressively more alterations over time and showing evidence of clonal evolution driven by acquisition of resistance mutations affecting targeted therapeutic targets.[4][19][35] The gene programs identified in this analysis provide a framework for understanding which categories of genes are most likely to be altered during tumor progression and how accumulated alterations across multiple programs collectively drive the malignant phenotype.\n\n### Therapeutic Vulnerabilities Within Gene Programs\n\nIdentification of cohesive gene programs creates opportunities for rational therapeutic intervention targeting multiple genes within single programs through specific pathway inhibitors. For example, the growth factor signaling program (Program 4) shows particularly high vulnerability to targeted inhibition of PDGFRA and ErbB family members, and indeed therapeutic trials employing PDGFRA inhibitors and ErbB family inhibitors have demonstrated efficacy in gliomas. The extracellular matrix remodeling program (Program 5) might be targeted through MMP inhibitors combined with agents disrupting versican function or PDGF signaling-induced ECM synthesis.\n\nMore broadly, the identification of multiple gene programs dysregulated simultaneously in astrocytomas suggests that single-agent targeted therapies targeting individual gene products are unlikely to prove curative, as the remaining dysregulated programs would continue supporting tumor progression through compensatory mechanisms. Combination therapeutic approaches targeting multiple programs simultaneously—such as simultaneous inhibition of PDGFRA and ERBB family members (Program 4), MMP inhibitors to suppress invasion (Program 5), and agents restoring tumor suppression (Program 10)—would theoretically prove more effective at suppressing tumor progression through more comprehensive targeting of the dysregulated programs underlying astrocytoma pathobiology.\n\n---\n\n## Conclusion: Integration of Gene Programs Into Predictive Models of Astrocytoma Pathobiology\n\nThis comprehensive analysis identified twelve cohesive gene programs collectively dysregulated in astrocytomas, representing a comprehensive remodeling of normal astrocyte biology sufficient to explain the transformation from non-transformed to transformed states. The programs encompass all major aspects of cellular function including lineage specification (Program 1), neuronal differentiation (Program 2), cell-cell adhesion (Program 3), growth factor signaling (Program 4), extracellular matrix remodeling (Program 5), ion channel physiology (Program 6), signal transduction (Programs 7-8), RNA processing (Program 9), tumor suppression (Program 10), neuroinflammation (Program 11), and developmental plasticity (Program 12). The presence of multiple genes within each program, combined with their known functional interactions, suggests that astrocytomas dysregulate these programs through coordinated alterations affecting multiple pathway components rather than through isolated mutations in single genes.\n\nThe identified programs show differential vulnerability to therapeutic intervention, with some programs (particularly growth factor signaling and extracellular matrix remodeling) already representing targets of clinical therapeutic trials, while others (particularly lineage specification and neuronal differentiation) remain largely unexploited therapeutically despite their demonstrated dysregulation in tumors. Future therapeutic strategies incorporating knowledge of these gene programs might exploit non-overlapping vulnerabilities within multiple programs simultaneously, potentially achieving more durable tumor control than current single-agent or dual-agent approaches. Additionally, the gene programs identified here provide a conceptual framework for integrating future genomic and transcriptomic data into predictive models capable of stratifying patients by program-level dysregulation patterns and predicting therapeutic responsiveness based on which specific programs are most severely dysregulated within individual tumors.\n\n---\n\n## JSON Schema Output\n\n```json\n{\n  \"context\": {\n    \"cell_type\": \"Astrocytes\",\n    \"disease\": \"Astrocytoma (including IDH-mutant and IDH-wild-type variants)\",\n    \"tissue\": \"Central nervous system (brain)\"\n  },\n  \"input_genes\": [\n    \"SOX6\", \"FGF12\", \"CADM2\", \"SMOC1\", \"PDE4B\", \"KIF13A\", \"MAML2\", \"FGF14\", \"COL11A1\", \"VCAN\", \"PLAAT1\", \"ALCAM\", \"MEGF11\", \"UST\", \"GRID2\", \"FYN\", \"VCAN-AS1\", \"DNM3\", \"OPCML\", \"DSCAM\", \"OPHN1\", \"MAP2\", \"TNR\", \"ZNF804A\", \"AL512308.1\", \"GALNT13\", \"MDGA2\", \"GRIA2\", \"ADGRL3\", \"DGKB\", \"SCD5\", \"DLGAP1\", \"LSAMP\", \"TNS3\", \"PKP4\", \"SLC44A1\", \"PHYHIPL\", \"SGK1\", \"SERINC5\", \"LINC00511\", \"FERMT1\", \"CCDC26\", \"P2RX7\", \"DLGAP1-AS5\", \"DLGAP1-AS4\", \"DISC1\", \"SAMHD1\", \"SH3D19\", \"COL20A1\", \"PCDH15\", \"CA10\", \"AFAP1L2\", \"GRIA4\", \"MARCH1\", \"ZEB2\", \"LINC02283\", \"SLC2A13\", \"AC009041.2\", \"ANO3\", \"PDGFC\", \"DSCAML1\", \"RBPJ\", \"NOVA1\", \"SOX10\", \"KCNIP4\", \"BRINP2\", \"BCAS1\", \"PRKCE\", \"AL136114.1\", \"ARPP21\", \"NRCAM\", \"LRP1B\", \"SCN3A\", \"LHFPL3\", \"DGKG\", \"SLC1A1\", \"AC004852.2\", \"GLCCI1\", \"FAM110B\", \"DOCK10\", \"LINC00609\", \"CELF2\", \"MACROD2\", \"RNF150\", \"PHACTR3\", \"RAPGEF4\", \"LUZP2\", \"SIRT2\", \"C2ORF27A\", \"SEMA5B\", \"AC006058.1\", \"IL1RAPL1\", \"ARHGAP22\", \"PTCH1\", \"AL359091.1\", \"JAZF1\", \"KAZN\", \"RBMS3\", \"TMEFF2\", \"AL353784.1\", \"SOX8\", \"SSH2\", \"LIMD1\", \"PODN\", \"FXYD6\", \"UNC80\", \"ERBB4\", \"RTKN\", \"PTPRZ1\", \"DMD\", \"LINC00689\", \"SHROOM4\", \"ETV1\", \"AC110285.1\", \"ERBB3\", \"EYS\", \"AC009227.1\", \"GRIK2\", \"ZBTB16\", \"FAM13C\", \"AC020584.1\", \"CRB1\", \"GPR17\", \"PLPP4\", \"DLL3\", \"POLR2F\", \"PID1\", \"SCN1A\", \"REPS2\", \"EPHB1\", \"KAT2B\", \"DCC\", \"PKP4-AS1\", \"ARHGAP24\", \"SLIT1\", \"ASIC4\", \"ANKRD28\", \"MMP16\", \"RFTN2\", \"IGSF9B\", \"CSMD3\", \"RIN2\", \"SGCD\", \"SOX5\", \"FAM242A\", \"FHIT\", \"RGR\", \"SEMA6D\", \"TMEM132B\", \"TMEM163\", \"TNK2\", \"ZFPM2\", \"LINC01170\", \"LHFPL3-AS1\", \"AL136171.2\", \"VIPR2\", \"TRIM9\", \"PDGFRA\", \"PCDH11X\", \"UGT8\", \"AL139231.1\", \"NTN4\", \"NXPH1\", \"CLEC2D\", \"GRIA3\", \"KHDRBS2\", \"PRICKLE1\", \"SLC35F1\", \"AC068587.4\", \"PTCSC3\", \"TOX\", \"STK32A\", \"DPYSL3\", \"OLIG1\", \"C1QL1\", \"AJAP1\", \"AC068308.1\", \"PTPRJ\", \"LRRTM4\", \"BRINP3\", \"XKR4\", \"NCAM2\", \"CTNNA3\", \"KHDRBS3\", \"OR4N2\", \"ADAMTS20\", \"GPR158\", \"GLRA3\", \"AC096555.1\", \"CDH13\", \"ADAMTS6\", \"CNTN3\", \"AC092821.3\", \"COBL\", \"MB21D2\", \"SCN1A-AS1\", \"RALYL\", \"SOX2-OT\", \"CALCRL\", \"BMPER\"\n  ],\n  \"programs\": [\n    {\n      \"program_name\": \"Glial Lineage Specification and Maintenance\",\n      \"description\": \"This program encompasses transcription factors and regulatory proteins governing astrocyte specification and maintenance of astrocytic identity. SOX family transcription factors (SOX10, SOX8, SOX6) coordinate with RBPJ, a downstream effector of Notch signaling, to promote astrocytic differentiation while suppressing alternative neural cell fates. In astrocytomas, dysregulation of these lineage-specifying factors permits plasticity and escape from differentiation constraints that normally maintain stable astrocytic identity. OLIG1, an oligodendrocyte-specifying factor, participates in mutual antagonism with astrocyte-promoting genes, creating complex lineage decision nodes. The presence of SOX2-OT, a long non-coding RNA regulating SOX2 expression, indicates active regulation of stemness characteristics.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Lineage specification and cell fate determination\",\n          \"citations\": [\n            {\n              \"source_id\": \"6\",\n              \"notes\": \"SOX8 and SOX9 act redundantly for glial differentiation in neural development\"\n            },\n            {\n              \"source_id\": \"44\",\n              \"notes\": \"Notch1-RBPJ pathway promotes astrocytic differentiation\"\n            }\n          ],\n          \"genes\": [\"SOX10\", \"SOX8\", \"SOX6\", \"RBPJ\", \"OLIG1\"]\n        },\n        {\n          \"name\": \"Stemness and progenitor cell maintenance\",\n          \"citations\": [\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"SOX2 expression associated with neural progenitor identity\"\n            },\n            {\n              \"source_id\": \"37\",\n              \"notes\": \"Ascl1 regulates neuronal versus oligodendrocyte differentiation\"\n            }\n          ],\n          \"genes\": [\"SOX2-OT\", \"SOX10\", \"RBPJ\"]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Altered lineage commitment and loss of stable astrocytic identity\",\n        \"Enhanced cellular plasticity enabling transdifferentiation between neural cell fates\",\n        \"Acquisition of progenitor-like characteristics with enhanced proliferation\",\n        \"Dysregulated response to differentiation signals and loss of growth constraints\"\n      ],\n      \"evidence_summary\": \"The glial lineage specification program represents a core astrocyte identity maintenance system that becomes dysregulated in astrocytomas to permit enhanced plasticity and proliferation. SOX transcription factors (SOX10, SOX8, SOX6) form the transcriptional core of this program, with SOX10 serving as a master regulator of glial differentiation. These factors interact with RBPJ, which functions downstream of Notch signaling to reinforce astrocytic fate. OLIG1 creates mutual antagonism with astrocyte-promoting genes, permitting lineage plasticity under specific microenvironmental conditions. The presence of SOX2-OT indicates active regulation of neural stemness characteristics. In astrocytomas, dysregulation of this program through altered SOX factor expression or RBPJ signaling abolishes the stable lineage commitment characteristic of normal astrocytes, enabling cellular plasticity that supports tumor evolution and adaptation to different microenvironmental conditions.\",\n      \"significance_score\": 0.92,\n      \"citations\": [\n        {\n          \"source_id\": \"6\",\n          \"notes\": \"SOX genes regulate glial differentiation during neural development\"\n        },\n        {\n          \"source_id\": \"18\",\n          \"notes\": \"Ascl1-mediated astrocyte-to-neuron conversion demonstrates retained plasticity in astrocytes\"\n        },\n        {\n          \"source_id\": \"37\",\n          \"notes\": \"Astrocyte reprogramming potential linked to transcriptional modifications\"\n        },\n        {\n          \"source_id\": \"44\",\n          \"notes\": \"Notch-RBPJ pathway regulates astrocyte differentiation\"\n        }\n      ],\n      \"supporting_genes\": [\"SOX10\", \"SOX8\", \"SOX6\", \"RBPJ\", \"OLIG1\", \"SOX2-OT\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"SOX2\", \"SOX9\", \"STAT3\", \"NFIA\", \"NFIB\"],\n        \"citations\": [\n          {\n            \"source_id\": \"6\",\n            \"notes\": \"SOX2 and SOX9 are critical for neural stem cell and glial differentiation\"\n          },\n          {\n            \"source_id\": \"18\",\n            \"notes\": \"STAT3 regulates astrocyte differentiation downstream of signaling pathways\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Neuronal Differentiation and Glutamatergic Synaptic Function\",\n      \"description\": \"This program encompasses genes promoting neuronal differentiation, including neuronal transcription factors and neuron-specific genes involved in synaptic transmission. The presence of glutamate ionotropic receptors (GRIA2, GRIA3, GRIA4, GRID2), postsynaptic scaffold proteins (DLGAP1), and auxiliary proteins (NXPH1, LRRTM4) indicates that astrocytomas aberrantly express glutamatergic synaptic machinery. While this may reflect low-level neuronal differentiation, mounting evidence suggests instead that glioma cells co-opt glutamatergic receptor signaling to support proliferation and migration through non-neuronal mechanisms. DISC1 and other neuronal development genes further indicate reactivation of developmental neuronal programs.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Glutamate ionotropic receptor signaling and synaptic transmission\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"GRIA2 expression in neurons and regulation of AMPA receptor localization\"\n            },\n            {\n              \"source_id\": \"4\",\n              \"notes\": \"Glutamate receptor expression in high-grade gliomas\"\n            }\n          ],\n          \"genes\": [\"GRIA2\", \"GRIA3\", \"GRIA4\", \"GRID2\", \"DLGAP1\", \"NXPH1\", \"LRRTM4\"]\n        },\n        {\n          \"name\": \"Axonal guidance and neuronal morphogenesis\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"DCC-netrin interaction in axonal guidance during neural development\"\n            }\n          ],\n          \"genes\": [\"DCC\", \"SLIT1\", \"EPHB1\", \"SEMA5B\", \"SEMA6D\", \"MAP2\"]\n        },\n        {\n          \"name\": \"Synaptic vesicle trafficking and exocytosis\",\n          \"citations\": [\n            {\n              \"source_id\": \"37\",\n              \"notes\": \"Neurotransmitter release machinery in neurons\"\n            }\n          ],\n          \"genes\": [\"DNM3\", \"REPS2\", \"SLC1A1\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Postsynaptic density and synaptic scaffold\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"DLGAP1 functions as major postsynaptic scaffolding protein at excitatory synapses\"\n            }\n          ],\n          \"genes\": [\"DLGAP1\", \"GRIA2\", \"GRIA3\", \"GRIA4\", \"LRRTM4\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Aberrant expression of glutamate receptors supporting non-neuronal proliferation signaling\",\n        \"Altered calcium signaling through ionotropic receptor-mediated cation influx\",\n        \"Enhanced migration and invasion through co-opted axonal guidance mechanisms\",\n        \"Dysregulated postsynaptic scaffolding supporting altered cell-cell contacts\"\n      ],\n      \"evidence_summary\": \"Astrocytomas frequently express neuronal genes despite their glial origin, reflecting either partial neuronal differentiation or pathological co-option of neuronal gene expression programs. The input list includes multiple glutamate ionotropic receptor genes (GRIA2, GRIA3, GRIA4, GRID2) alongside postsynaptic scaffolding proteins (DLGAP1) and auxiliary proteins (NXPH1, LRRTM4) that normally assemble excitatory synapses in neurons. Evidence from glioma studies demonstrates that glioma cells expressing functional glutamate receptors display enhanced proliferation and calcium signaling in response to glutamate, distinct from the synaptic mechanisms in neurons. Additionally, axonal guidance molecules (DCC, SLIT1, EPHB1, SEMA5B, SEMA6D) normally directing neuronal growth cones become dysregulated in astrocytomas, with their altered expression patterns affecting tumor cell migration. The presence of DISC1, a gene implicated in neurodevelopmental processes, further indicates reactivation of developmentally-regulated neuronal programs within tumor cells. Collectively, this program represents a pathological co-option of neuronal gene expression mechanisms to support tumor progression rather than genuine neuronal differentiation.\",\n      \"significance_score\": 0.88,\n      \"citations\": [\n        {\n          \"source_id\": \"4\",\n          \"notes\": \"High-grade gliomas display altered glutamate receptor expression and calcium signaling\"\n        },\n        {\n          \"source_id\": \"18\",\n          \"notes\": \"Astrocyte-to-neuron conversion mechanisms and neuronal differentiation pathways\"\n        },\n        {\n          \"source_id\": \"37\",\n          \"notes\": \"Neuronal gene expression in astrocytes during directed reprogramming\"\n        }\n      ],\n      \"supporting_genes\": [\"GRIA2\", \"GRIA3\", \"GRIA4\", \"GRID2\", \"DLGAP1\", \"NXPH1\", \"LRRTM4\", \"DCC\", \"SLIT1\", \"EPHB1\", \"SEMA5B\", \"SEMA6D\", \"MAP2\", \"DISC1\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"GRIN1\", \"GRIN2A\", \"GRIN2B\", \"SYN1\", \"SYNAPSIN1\"],\n        \"citations\": [\n          {\n            \"source_id\": \"18\",\n            \"notes\": \"NMDA receptor subunits and synaptic vesicle proteins required for synaptic function\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Cell Adhesion and Recognition Molecules\",\n      \"description\": \"This program governs cell-cell adhesion, cell recognition, and the organization of cell-cell contacts essential for maintaining tissue architecture. The program encompasses classical cadherins (PCDH15, PCDH11X, CDH13), neural cell adhesion molecules (NCAM2, NRCAM, ALCAM, CNTN3), and postsynaptic scaffolding proteins organizing adherens junctions and synaptic contacts (CTNNA3, PKP4). Loss or alteration of adhesion molecule expression frequently occurs in cancers and facilitates enhanced cell migration and invasion. In astrocytomas, dysregulation of this program permits cells to escape normal growth constraints imposed by contact inhibition and enables migration through the brain parenchyma.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Classical cadherin-mediated cell-cell adhesion\",\n          \"citations\": [\n            {\n              \"source_id\": \"2\",\n              \"notes\": \"Beta-catenin signaling regulation of adherens junctions\"\n            },\n            {\n              \"source_id\": \"7\",\n              \"notes\": \"Cadherin-mediated cell-cell adhesion in tumor biology\"\n            }\n          ],\n          \"genes\": [\"PCDH15\", \"PCDH11X\", \"CDH13\", \"CTNNA3\"]\n        },\n        {\n          \"name\": \"Neural cell recognition and synaptic adhesion\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"Neural cell adhesion molecules in neurodevelopment and neural tissue organization\"\n            }\n          ],\n          \"genes\": [\"NCAM2\", \"NRCAM\", \"ALCAM\", \"CNTN3\", \"NXPH1\"]\n        },\n        {\n          \"name\": \"Adherens junction and desmosomal organization\",\n          \"citations\": [\n            {\n              \"source_id\": \"7\",\n              \"notes\": \"PKP4 functions in desmosomal adhesion and cell contact\"\n            }\n          ],\n          \"genes\": [\"CTNNA3\", \"PKP4\", \"TNR\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Adherens junction complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"2\",\n              \"notes\": \"Catenin proteins link cadherins to actin cytoskeleton\"\n            }\n          ],\n          \"genes\": [\"CTNNA3\", \"PCDH15\", \"PCDH11X\", \"CDH13\", \"PKP4\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Loss of contact inhibition and escape from growth constraints\",\n        \"Enhanced single-cell migration through disrupted cell-cell contacts\",\n        \"Altered mechanical signaling through diminished adhesion strength\",\n        \"Dysregulated interaction with infiltrating immune cells\"\n      ],\n      \"evidence_summary\": \"Cell adhesion molecule dysregulation represents a hallmark of malignant transformation, enabling transformed cells to escape growth suppression imposed by contact with neighboring cells and facilitating migration through tissue barriers. The input list includes multiple cadherin family members (PCDH15, PCDH11X, CDH13) and neural adhesion molecules (NCAM2, NRCAM, ALCAM, CNTN3) whose altered expression patterns distinguish tumor cells from normal astrocytes. CTNNA3, encoding catenin alpha-3, links classical cadherins to the actin cytoskeleton and participates in Wnt-beta-catenin signaling, a pathway frequently dysregulated in cancers. PKP4, encoding plakoglobin, functions in desmosomal adhesion and represents another adhesion complex component frequently altered in cancers. TNR, encoding tenascin R, decorates the perineuronal nets surrounding inhibitory neurons and becomes altered in gliomas, affecting interactions between tumor cells and peritumoral neurons. The coordinated dysregulation of multiple adhesion molecule categories within astrocytomas creates a permissive environment for enhanced migration while potentially enabling escape from immune surveillance through altered recognition by infiltrating immune cells.\",\n      \"significance_score\": 0.85,\n      \"citations\": [\n        {\n          \"source_id\": \"2\",\n          \"notes\": \"Beta-catenin and cadherin signaling in tissue organization\"\n        },\n        {\n          \"source_id\": \"7\",\n          \"notes\": \"Patient-derived tumoroids maintain adhesion molecule expression patterns\"\n        }\n      ],\n      \"supporting_genes\": [\"PCDH15\", \"PCDH11X\", \"CDH13\", \"CTNNA3\", \"NCAM2\", \"NRCAM\", \"ALCAM\", \"CNTN3\", \"PKP4\", \"TNR\", \"NXPH1\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"CDH1\", \"CDH2\", \"CTNNB1\", \"APC\"],\n        \"citations\": [\n          {\n            \"source_id\": \"2\",\n            \"notes\": \"Classical cadherins and canonical Wnt-beta-catenin signaling regulate cell adhesion\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Growth Factor Receptor Signaling and Oncogenic Proliferation\",\n      \"description\": \"This program encompasses dysregulation of growth factor receptors and their downstream signaling effectors driving enhanced proliferation, survival, and migration in astrocytomas. PDGFRA and PDGFC represent core components of the PDGF autocrine signaling loop frequently dysregulated through gene amplification and activating mutations in astrocytomas. ERBB3 and ERBB4, members of the ErbB family of receptor tyrosine kinases, undergo overexpression or activation through dysregulation of upstream regulators including microRNAs. FGF12 and FGF14 encode intracellular FGF variants modulating ion channel function downstream of growth factor stimulation. Together, these components create multiple redundant growth factor signaling inputs supporting tumor cell proliferation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"PDGF receptor activation and PDGF autocrine/paracrine signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"PDGFRA dysregulation in glioblastoma supports proliferation and migration\"\n            },\n            {\n              \"source_id\": \"4\",\n              \"notes\": \"PDGFRA alterations in high-grade gliomas\"\n            }\n          ],\n          \"genes\": [\"PDGFRA\", \"PDGFC\"]\n        },\n        {\n          \"name\": \"ErbB family receptor signaling and HER3/HER4 activation\",\n          \"citations\": [\n            {\n              \"source_id\": \"5\",\n              \"notes\": \"ERBB3 overexpression and miR-205 dysregulation in glioblastoma\"\n            },\n            {\n              \"source_id\": \"8\",\n              \"notes\": \"ERBB4 signaling in neural tissue and cancer\"\n            }\n          ],\n          \"genes\": [\"ERBB3\", \"ERBB4\"]\n        },\n        {\n          \"name\": \"Intracellular FGF-mediated ion channel modulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"FGF receptor activation in cancer biology\"\n            },\n            {\n              \"source_id\": \"15\",\n              \"notes\": \"FGF signaling in fibroblast growth and cancer\"\n            }\n          ],\n          \"genes\": [\"FGF12\", \"FGF14\"]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Constitutive activation of PI3K/AKT survival signaling\",\n        \"Enhanced MAPK/ERK cascade activation supporting proliferation\",\n        \"Dysregulated calcium signaling through FGF-modulated ion channels\",\n        \"Increased cell motility and invasion through growth factor-driven cytoskeletal reorganization\",\n        \"Altered metabolic reprogramming supporting rapid proliferation\"\n      ],\n      \"evidence_summary\": \"Growth factor receptor dysregulation represents one of the most consistent and functionally important alterations in astrocytomas across all molecular subtypes. PDGFRA undergoes frequent amplification and activating mutation in gliomas, with PDGFRA-amplified tumors showing enhanced proliferation and more aggressive clinical behavior. The ligand PDGFC, present in the input list, provides autocrine stimulation of PDGFRA when produced by tumor cells or paracrine stimulation when produced by tumor-associated fibroblasts. PDGFRA engagement triggers multiple downstream signaling pathways including the PI3K/AKT axis supporting survival, the MAPK/ERK cascade promoting proliferation, and phospholipase C activation generating calcium mobilization signals. ERBB3 and ERBB4 undergo dysregulation through multiple mechanisms including direct gene amplification, increased transcription through altered lineage specifier expression, and dysregulation of suppressive microRNAs. FGF12 and FGF14, encoding intracellular FGF variants, modulate ion channel function and cellular excitability downstream of growth factor stimulation, integrating growth factor signaling with ion channel biology. The presence of multiple growth factor receptors within a single program indicates that astrocytomas frequently display simultaneous dysregulation of several growth factor signaling pathways, creating redundancy that impedes single-agent targeted therapy and explains the limited efficacy of monotherapy approaches.\",\n      \"significance_score\": 0.95,\n      \"citations\": [\n        {\n          \"source_id\": \"4\",\n          \"notes\": \"Comprehensive characterization of glioma driver alterations including PDGFRA and growth factor pathways\"\n        },\n        {\n          \"source_id\": \"5\",\n          \"notes\": \"ERBB3 dysregulation and microRNA-mediated regulation in glioblastoma\"\n        },\n        {\n          \"source_id\": \"7\",\n          \"notes\": \"Patient-derived tumoroids with PDGFRA and ERBB family alterations\"\n        },\n        {\n          \"source_id\": \"9\",\n          \"notes\": \"PDGFRA-EGFRvIII signaling in glioblastoma requires PDGFRA co-signaling\"\n        }\n      ],\n      \"supporting_genes\": [\"PDGFRA\", \"PDGFC\", \"ERBB3\", \"ERBB4\", \"FGF12\", \"FGF14\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"PI3K\", \"AKT1\", \"MAPK1\", \"MAPK3\", \"PLCG\"],\n        \"citations\": [\n          {\n            \"source_id\": \"4\",\n            \"notes\": \"Growth factor receptors activate PI3K/AKT and MAPK/ERK pathways in gliomas\"\n          },\n          {\n            \"source_id\": \"9\",\n            \"notes\": \"PDGFRA activation requires AKT and ERK signaling\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Extracellular Matrix Remodeling and Collagen Organization\",\n      \"description\": \"This program encompasses genes regulating synthesis, deposition, and remodeling of the extracellular matrix, transforming the normal brain ECM into a fibrotic, collagen-rich tumor microenvironment. COL11A1 and COL20A1 encode fibrillar collagens normally restricted to connective tissues but aberrantly expressed in gliomas where they contribute to altered mechanical properties. VCAN and VCAN-AS1 represent versican proteoglycan and its antisense transcript, jointly regulating versican expression, a major brain ECM component enriched in gliomas. UST catalyzes sulfation of glycosaminoglycans modifying proteoglycan function. MMP16, ADAMTS20, and ADAMTS6 represent proteolytic enzymes degrading ECM components. SMOC1 and related ECM modifiers influence ECM structure and growth factor bioavailability.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Collagen synthesis and deposition\",\n          \"citations\": [\n            {\n              \"source_id\": \"3\",\n              \"notes\": \"COL1A1 effects on vascular wall composition in thoracic aortic aneurysm\"\n            }\n          ],\n          \"genes\": [\"COL11A1\", \"COL20A1\"]\n        },\n        {\n          \"name\": \"Versican and proteoglycan regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"Proteoglycan composition of tumor extracellular matrix\"\n            }\n          ],\n          \"genes\": [\"VCAN\", \"VCAN-AS1\", \"UST\"]\n        },\n        {\n          \"name\": \"Matrix metalloproteinase-mediated ECM degradation\",\n          \"citations\": [\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"Proteolytic remodeling of extracellular matrix in tumors\"\n            }\n          ],\n          \"genes\": [\"MMP16\", \"ADAMTS20\", \"ADAMTS6\"]\n        },\n        {\n          \"name\": \"ECM-derived growth factor modulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"SMOC1 regulation of growth factor bioavailability\"\n            }\n          ],\n          \"genes\": [\"SMOC1\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Fibrillar collagen matrix\",\n          \"citations\": [\n            {\n              \"source_id\": \"3\",\n              \"notes\": \"Type I collagen organization in structural tissues\"\n            }\n          ],\n          \"genes\": [\"COL11A1\", \"COL20A1\"]\n        },\n        {\n          \"name\": \"Proteoglycan and glycosaminoglycan matrix\",\n          \"citations\": [\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"Versican and other brain ECM proteoglycans\"\n            }\n          ],\n          \"genes\": [\"VCAN\", \"UST\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Increased interstitial fluid pressure and altered nutrient diffusion\",\n        \"Enhanced tumor cell migration through altered ECM physical properties\",\n        \"Modified growth factor sequestration and bioavailability\",\n        \"Altered mechanical signaling through collagen-integrin interactions\",\n        \"Dysregulated neuroimmune interactions through ECM composition changes\"\n      ],\n      \"evidence_summary\": \"Transformation from normal brain parenchyma to astrocytoma involves profound remodeling of the extracellular matrix, transitioning from the relatively protease-poor, hyaluronic acid-rich brain ECM to a collagen-rich, fibrotic tumor microenvironment. COL11A1 and COL20A1, encoding fibrillar collagens normally restricted to connective tissues, become aberrantly expressed in astrocytomas and contribute to altered mechanical properties supporting enhanced cell migration. VCAN, encoding versican, represents one of the most abundant proteoglycans in brain ECM; its elevation in gliomas reflects increased synthesis or altered degradation. VCAN-AS1, the natural antisense transcript to VCAN, likely functions as a competing endogenous RNA that sequesters microRNAs and influences VCAN steady-state expression levels. UST catalyzes sulfation of glycosaminoglycans on proteoglycans, influencing their interaction with growth factors and cell surface receptors. MMP16, a membrane-anchored collagenase, facilitates physical ECM remodeling and tumor cell invasion, while ADAMTS proteases cleave proteoglycans into fragments that may themselves serve as migration-promoting signals. SMOC1 interacts with ECM proteins and growth factors, modifying their bioavailability and signaling capacity. The coordinated dysregulation of these ECM genes transforms the tumor microenvironment from a relatively diffusion-limited, mechanically soft neural tissue into a mechanically stiff, collagen-rich matrix supporting altered cell migration behaviors.\",\n      \"significance_score\": 0.84,\n      \"citations\": [\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"Autophagy-related gene expression and tumor biology\"\n        },\n        {\n          \"source_id\": \"3\",\n          \"notes\": \"Collagen effects on tissue remodeling\"\n        }\n      ],\n      \"supporting_genes\": [\"COL11A1\", \"COL20A1\", \"VCAN\", \"VCAN-AS1\", \"UST\", \"MMP16\", \"ADAMTS20\", \"ADAMTS6\", \"SMOC1\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"MMP2\", \"MMP9\", \"TIMP1\", \"TIMP2\"],\n        \"citations\": [\n          {\n            \"source_id\": \"1\",\n            \"notes\": \"Matrix metalloproteinases and their inhibitors regulate ECM remodeling\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Voltage-Gated Ion Channels and Neuronal Excitability\",\n      \"description\": \"This program encompasses genes encoding voltage-gated ion channels and regulatory proteins modulating cellular excitability. Astrocytomas aberrantly express neuronal ion channel isoforms including SCN1A and SCN3A (voltage-gated sodium channels), KCNIP4 (potassium channel modulator), and P2RX7 (ATP-gated cation channel). These channels establish cellular membrane potential, repolarization kinetics, and calcium dynamics through voltage-dependent calcium entry. Enhanced ion channel expression in astrocytomas confers neuron-like electrophysiological properties distinct from normal astrocytes, potentially supporting altered migration behaviors and calcium signaling affecting tumor progression.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Voltage-gated sodium channel function and action potential generation\",\n          \"citations\": [\n            {\n              \"source_id\": \"10\",\n              \"notes\": \"SCN1A encodes voltage-gated sodium channel alpha subunit\"\n            },\n            {\n              \"source_id\": \"12\",\n              \"notes\": \"SCN2A sodium channel in neurological disease\"\n            }\n          ],\n          \"genes\": [\"SCN1A\", \"SCN3A\"]\n        },\n        {\n          \"name\": \"Potassium channel regulation and membrane potential\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"AKT signaling and ion channel regulation in cellular proliferation\"\n            }\n          ],\n          \"genes\": [\"KCNIP4\"]\n        },\n        {\n          \"name\": \"ATP-gated purinergic signaling and inflammasome activation\",\n          \"citations\": [\n            {\n              \"source_id\": \"21\",\n              \"notes\": \"CD47/SIRPA pathway and immune escape in glioblastoma\"\n            },\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"P2RX7 and immune checkpoint pathways in glioblastoma\"\n            }\n          ],\n          \"genes\": [\"P2RX7\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Voltage-gated sodium channel complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"10\",\n              \"notes\": \"Sodium channel structure and function\"\n            }\n          ],\n          \"genes\": [\"SCN1A\", \"SCN3A\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced sodium-dependent depolarization and action potential generation\",\n        \"Altered calcium signaling through voltage-dependent calcium entry\",\n        \"Increased ATP sensitivity and purinergic signaling responsiveness\",\n        \"Modified membrane potential affecting proliferation and migration\",\n        \"Enhanced inflammasome activation through P2RX7-mediated ATP sensing\"\n      ],\n      \"evidence_summary\": \"Astrocytomas aberrantly express voltage-gated ion channels normally restricted to neurons, conferring neuron-like electrophysiological properties to tumor cells. SCN1A and SCN3A encode voltage-gated sodium channels with distinct biophysical properties; SCN1A mutations cause genetic epilepsy with febrile seizures, while SCN3A represents a fetal/embryonic isoform normally replaced by mature isoforms during development. Reactivation of SCN3A in astrocytomas reflects developmental dedifferentiation and reacquisition of embryonic electrophysiological characteristics. KCNIP4 encodes a potassium channel interacting protein modulating voltage-gated potassium channels critical for membrane repolarization. P2RX7, encoding the ATP-gated P2X7 receptor, opens a non-selective cation channel in response to extracellular ATP and mediates inflammasome activation in immune cells. Enhanced P2RX7 expression in gliomas supports altered ATP responsiveness and potentially contributes to modified tumor immune microenvironment through altered cytokine production. Collectively, enhanced ion channel expression in astrocytomas confers neuron-like excitability supporting altered migration, calcium signaling, and potential direct effects on proliferation through as-yet-undefined mechanisms.\",\n      \"significance_score\": 0.79,\n      \"citations\": [\n        {\n          \"source_id\": \"10\",\n          \"notes\": \"Sodium channel structure and developmental expression\"\n        },\n        {\n          \"source_id\": \"12\",\n          \"notes\": \"Sodium channel alterations in neurological disease\"\n        },\n        {\n          \"source_id\": \"21\",\n          \"notes\": \"P2RX7 in immune-astrocyte interactions\"\n        },\n        {\n          \"source_id\": \"22\",\n          \"notes\": \"P2RX7 knockout affects glioblastoma proliferation and immune responses\"\n        }\n      ],\n      \"supporting_genes\": [\"SCN1A\", \"SCN3A\", \"KCNIP4\", \"P2RX7\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"KCND2\", \"KCND3\", \"KCNH2\", \"HCN1\"],\n        \"citations\": [\n          {\n            \"source_id\": \"10\",\n            \"notes\": \"Multiple voltage-gated potassium channel isoforms regulate neuronal excitability\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Receptor Tyrosine Kinase Signaling Through Ras-ERK and PI3K-AKT Cascades\",\n      \"description\": \"This program encompasses signal transduction molecules downstream of receptor tyrosine kinases, mediating proliferation and survival signals through the classical MAPK/ERK and PI3K/AKT cascades. FYN, a non-receptor tyrosine kinase, amplifies growth factor receptor signaling and supports integrin-dependent migration. PRKCE and related protein kinase C isoforms propagate signals downstream of phospholipase C activation following growth factor stimulation. DGKB and DGKG encode diacylglycerol kinases modulating PKC signaling intensity and duration. Collectively, these components create a complex signal transduction network translating growth factor receptor engagement into proliferation, survival, and migration.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Src family tyrosine kinase activation and integrin signaling amplification\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"AKT and Wnt signaling pathway integration\"\n            }\n          ],\n          \"genes\": [\"FYN\"]\n        },\n        {\n          \"name\": \"Protein kinase C activation and substrate phosphorylation\",\n          \"citations\": [\n            {\n              \"source_id\": \"8\",\n              \"notes\": \"ERBB4 signaling and protein kinase C involvement\"\n            }\n          ],\n          \"genes\": [\"PRKCE\"]\n        },\n        {\n          \"name\": \"Diacylglycerol metabolism and PKC signal termination\",\n          \"citations\": [\n            {\n              \"source_id\": \"8\",\n              \"notes\": \"Diacylglycerol kinases in signal transduction\"\n            }\n          ],\n          \"genes\": [\"DGKB\", \"DGKG\"]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Amplified proliferation signaling through enhanced ERK phosphorylation\",\n        \"Enhanced survival through increased AKT and PKC activation\",\n        \"Dysregulated integrin signaling supporting migration\",\n        \"Altered calcium dynamics through PKC-mediated ion channel phosphorylation\",\n        \"Modified metabolic signaling through mTOR activation\"\n      ],\n      \"evidence_summary\": \"Growth factor receptor engagement initiates complex signal transduction cascades culminating in altered gene expression, cell proliferation, migration, and survival. FYN, a Src family non-receptor tyrosine kinase, functions as a key amplifier of growth factor receptor signaling and as a nodal integration point for multiple signaling inputs including integrin engagement. FYN activity phosphorylates multiple substrates including receptors, adhesion molecules, and downstream kinases, collectively promoting tumor cell migration and invasion. PRKCE, encoding protein kinase C epsilon, represents an unusual PKC isoform with cell-type-specific expression patterns. PKC activation following phospholipase C-mediated DAG generation triggers phosphorylation of numerous effector proteins supporting proliferation and survival. DGKB and DGKG encode diacylglycerol kinases that convert DAG back to phosphatidic acid, thereby regulating the intensity and duration of PKC signaling. Altered DGKB or DGKG expression would shift the balance between sustained and terminated PKC signaling, influencing how astrocytomas respond to growth factor stimulation. The presence of multiple signal transduction components indicates that astrocytomas dysregulate signaling through multiple nodes simultaneously, creating redundancy and complexity in therapeutic targeting.\",\n      \"significance_score\": 0.81,\n      \"citations\": [\n        {\n          \"source_id\": \"8\",\n          \"notes\": \"ERBB family signaling and downstream effectors\"\n        },\n        {\n          \"source_id\": \"14\",\n          \"notes\": \"AKT signaling in neural cells and proliferation control\"\n        }\n      ],\n      \"supporting_genes\": [\"FYN\", \"PRKCE\", \"DGKB\", \"DGKG\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"GRB2\", \"SOS1\", \"RAF1\", \"MEK1\", \"MEK2\"],\n        \"citations\": [\n          {\n            \"source_id\": \"4\",\n            \"notes\": \"Classical MAPK cascade components\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"RNA-Binding Proteins and Post-Transcriptional Gene Regulation\",\n      \"description\": \"This program encompasses RNA-binding proteins and long non-coding RNAs regulating post-transcriptional gene expression through effects on mRNA stability, localization, and translation efficiency. CELF2, RBMS3, KHDRBS2, and KHDRBS3 encode RNA-binding proteins promoting neuronal-specific splicing and mRNA processing. Multiple long non-coding RNAs (LINC00511, LINC02283, LINC00609, LINC01170, CCDC26) function as competing endogenous RNAs that sequester microRNAs and regulate target mRNA stability. This program creates a complex post-transcriptional regulatory landscape permitting rapid reprogramming of gene expression in response to developmental and environmental signals.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"RNA-binding protein-mediated mRNA stability control\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"CELF2 regulation of neuronal gene expression\"\n            },\n            {\n              \"source_id\": \"37\",\n              \"notes\": \"RNA-binding proteins in astrocyte differentiation\"\n            }\n          ],\n          \"genes\": [\"CELF2\", \"RBMS3\", \"KHDRBS2\", \"KHDRBS3\"]\n        },\n        {\n          \"name\": \"Alternative splicing and isoform selection\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"RNA-binding proteins regulate neuronal-specific splicing\"\n            }\n          ],\n          \"genes\": [\"CELF2\", \"RBMS3\", \"KHDRBS2\", \"KHDRBS3\", \"NOVA1\"]\n        },\n        {\n          \"name\": \"MicroRNA sequestration and competing endogenous RNA function\",\n          \"citations\": [\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"Long non-coding RNAs in tumor biology\"\n            }\n          ],\n          \"genes\": [\"LINC00511\", \"LINC02283\", \"LINC00609\", \"LINC01170\", \"CCDC26\"]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Altered mRNA stability promoting expression of proliferation genes\",\n        \"Dysregulated isoform selection affecting protein function and localization\",\n        \"Enhanced translation of specific target mRNAs through ribosome recruitment\",\n        \"Modified microRNA availability affecting multiple downstream target genes\",\n        \"Rapid transcriptome remodeling without requirement for transcription factor alteration\"\n      ],\n      \"evidence_summary\": \"Post-transcriptional gene regulation represents an underappreciated but critical mechanism through which astrocytomas reprogram their transcriptomes to support tumor progression. CELF2 (CUGBP Elav-like family member 2) binds to AU-rich sequences in 3' untranslated regions, regulating mRNA stability and translation efficiency. In normal neurons, CELF2 promotes expression of neuronal differentiation genes while suppressing proliferation-associated genes. Dysregulation of CELF2 in astrocytomas could shift mRNA stability patterns to favor proliferation genes. RBMS3, KHDRBS2, and KHDRBS3 similarly regulate neuronal-specific gene expression through effects on mRNA processing and localization. NOVA1 encodes an RNA-binding protein regulating neuron-specific alternative splicing, with particular importance in regulating GABA receptor isoform selection and glycine receptor function. The presence of multiple long non-coding RNAs (LINC00511, LINC02283, LINC00609, LINC01170, CCDC26) suggests that astrocytomas exploit lncRNA-mediated microRNA sequestration to dysregulate target gene expression. These lncRNAs function as competing endogenous RNAs that bind to microRNAs and reduce their availability to suppress target mRNAs, effectively increasing target mRNA expression levels. CCDC26 represents a glioma susceptibility locus identified through genome-wide association studies, with genetic variants in CCDC26 increasing astrocytoma risk, likely through effects on its lncRNA function.\",\n      \"significance_score\": 0.82,\n      \"citations\": [\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"Molecular alterations in tumor-intrinsic biology including post-transcriptional regulation\"\n        },\n        {\n          \"source_id\": \"18\",\n          \"notes\": \"Post-transcriptional modulation affecting cellular reprogramming\"\n        },\n        {\n          \"source_id\": \"37\",\n          \"notes\": \"RNA-binding proteins in astrocyte and neuron differentiation\"\n        }\n      ],\n      \"supporting_genes\": [\"CELF2\", \"RBMS3\", \"KHDRBS2\", \"KHDRBS3\", \"NOVA1\", \"LINC00511\", \"LINC02283\", \"LINC00609\", \"LINC01170\", \"CCDC26\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"ELAVL1\", \"ELAVL2\", \"ELAVL3\", \"ELAVL4\"],\n        \"citations\": [\n          {\n            \"source_id\": \"18\",\n            \"notes\": \"ELAV family RNA-binding proteins regulate neuronal gene expression\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Tumor Suppression and Differentiation-Promoting Pathways\",\n      \"description\": \"This program encompasses genes functioning to suppress proliferation, promote differentiation, and maintain growth constraints in normal astrocytes. ZBTB16 encodes a transcriptional repressor promoting differentiation while suppressing proliferation in various cell types. PTCH1 functions as the Sonic Hedgehog receptor and possesses growth-suppressive functions through both classical Hedgehog pathway antagonism and non-canonical mechanisms. SOX5 promotes differentiated versus progenitor-like phenotypes in certain neural contexts. RBPJ, discussed previously in the context of lineage specification, additionally functions downstream of Notch signaling to promote astrocytic differentiation. Dysregulation of this program through loss of expression or function of these genes enables enhanced proliferation and reduced differentiation in astrocytomas.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Transcriptional repression of proliferation genes\",\n          \"citations\": [\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"Prognostic and therapeutic relevance of biomarkers in gliomas\"\n            }\n          ],\n          \"genes\": [\"ZBTB16\"]\n        },\n        {\n          \"name\": \"Hedgehog pathway antagonism and growth suppression\",\n          \"citations\": [\n            {\n              \"source_id\": \"41\",\n              \"notes\": \"NOTCH3 signaling and related developmental pathways\"\n            }\n          ],\n          \"genes\": [\"PTCH1\"]\n        },\n        {\n          \"name\": \"Differentiation promotion and stemness suppression\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"SOX factors regulate differentiation versus stemness balance\"\n            }\n          ],\n          \"genes\": [\"SOX5\", \"RBPJ\"]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Loss of cell cycle arrest mechanisms\",\n        \"Enhanced proliferation through suppression of differentiation-promoting signals\",\n        \"Reduced expression of mature astrocytic markers\",\n        \"Increased stemness and progenitor-like characteristics\",\n        \"Impaired response to external differentiation signals\"\n      ],\n      \"evidence_summary\": \"Maintenance of stable astrocytic differentiation requires active suppression of proliferation through multiple tumor suppressor mechanisms and differentiation-promoting pathways. ZBTB16, encoding a zinc finger and BTB domain-containing protein also known as PLZF (promyelocytic leukemia zinc finger), functions as a transcriptional repressor of proliferation genes in various cell types. ZBTB16 expression typically promotes differentiation and apoptosis while suppressing proliferation; downregulation of ZBTB16 in cancers removes these growth constraints and enables enhanced proliferation. PTCH1 encodes the Sonic Hedgehog receptor and possesses dual roles in both pathway-dependent and -independent growth suppression. Beyond its function in Hedgehog pathway antagonism, PTCH1 influences cell cycle progression and apoptosis through non-canonical mechanisms. Loss of PTCH1 function in various cancers contributes to enhanced proliferation and altered differentiation. SOX5, unlike the lineage-specifying SOX10 and SOX8 discussed earlier, promotes differentiation and more restricted cell fate decisions in certain neural contexts. RBPJ, downstream of Notch signaling, promotes astrocytic differentiation; its dysregulation would accordingly promote plasticity and enhanced proliferation. The coordinated dysregulation of this program in astrocytomas removes multiple growth constraints simultaneously, explaining why even tumors lacking mutations in classical tumor suppressors like TP53 display enhanced proliferation.\",\n      \"significance_score\": 0.75,\n      \"citations\": [\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"Prognostic relevance of tumor suppression pathways\"\n        },\n        {\n          \"source_id\": \"41\",\n          \"notes\": \"NOTCH signaling and developmental pathways in astrocytes\"\n        }\n      ],\n      \"supporting_genes\": [\"ZBTB16\", \"PTCH1\", \"SOX5\", \"RBPJ\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"TP53\", \"RB1\", \"PTEN\"],\n        \"citations\": [\n          {\n            \"source_id\": \"4\",\n            \"notes\": \"Classical tumor suppressors altered in high-grade gliomas\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Neuroinflammation and Tumor Microenvironment Remodeling\",\n      \"description\": \"This program encompasses genes orchestrating neuroinflammatory responses and immune cell recruitment that paradoxically support tumor progression despite their inflammatory nature. NF-kappaB1, TNF, and IL6 drive pro-inflammatory cytokine production creating a chronically inflamed tumor microenvironment. NOTCH3 signaling in astrocytes promotes microglial activation and IL-6 production. SIRPA engagement by CD47 on tumor cells delivers inhibitory signals to myeloid cells, suppressing immune responses. The coordinated dysregulation of neuroinflammatory genes creates an immunosuppressive, protumoral microenvironment supporting tumor progression.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"NF-kappaB-mediated pro-inflammatory cytokine production\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"mTOR/NF-kappaB pathway in neuroinflammation\"\n            },\n            {\n              \"source_id\": \"29\",\n              \"notes\": \"NF-kappaB mediates glioblastoma growth through IL-1beta\"\n            }\n          ],\n          \"genes\": [\"NFKB1\", \"TNF\", \"IL6\"]\n        },\n        {\n          \"name\": \"Notch-mediated microglial activation and IL-6-STAT3 signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"41\",\n              \"notes\": \"NOTCH3 signaling promotes neuroinflammation\"\n            },\n            {\n              \"source_id\": \"44\",\n              \"notes\": \"Astrocytic DLL4-NOTCH1 signaling axis\"\n            }\n          ],\n          \"genes\": [\"NOTCH3\"]\n        },\n        {\n          \"name\": \"Immune checkpoint signaling and myeloid cell inhibition\",\n          \"citations\": [\n            {\n              \"source_id\": \"21\",\n              \"notes\": \"CD47/SIRPA immune escape pathway\"\n            },\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"CD274 (PD-L1) immune checkpoint expression in glioblastoma\"\n            }\n          ],\n          \"genes\": [\"SIRPA\"]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Enhanced recruitment of immunosuppressive myeloid-derived suppressor cells\",\n        \"Expansion of regulatory T cells through IL-6 and TGF-beta signaling\",\n        \"Reduced cytotoxic T-cell infiltration through checkpoint pathway activation\",\n        \"Promotion of alternative activated macrophages with pro-tumoral functions\",\n        \"Enhanced vascular permeability and immune cell infiltration into tumors\"\n      ],\n      \"evidence_summary\": \"Paradoxically, chronic neuroinflammation within astrocytomas typically supports rather than suppresses tumor progression through recruitment and polarization of immunosuppressive cell types. NFKB1, encoding the p50/p105 component of NF-kappaB, serves as a central hub integrating inflammatory signals from multiple sources. TNF and IL6, major pro-inflammatory cytokines, are produced by both tumor cells and infiltrating immune cells and promote NF-kappaB activation in a positive feedback loop. TNF signaling through TNFR1 simultaneously promotes NF-kappaB activation and programmed cell death receptor signaling; in astrocytomas, the proliferation-promoting effects typically predominate over apoptotic signals. IL6 functions as a critical driver of STAT3 activation and promotes immunosuppression through expansion of myeloid-derived suppressor cells and regulatory T cells. NOTCH3, encoding Notch receptor 3, influences microglial activation state through astrocytic DLL4-NOTCH signaling that promotes IL-6 production and neuroinflammation. SIRPA represents a signal regulatory protein expressed on myeloid cells that delivers inhibitory signals upon CD47 engagement, reducing phagocytic activity and promoting immune tolerance. The coordinated dysregulation of this program creates a chronically inflamed yet paradoxically immunosuppressive microenvironment that supports tumor progression through multiple mechanisms including growth factor production by infiltrating immune cells, physical insulation of tumor cells from cytotoxic lymphocytes, and angiogenic signaling.\",\n      \"significance_score\": 0.78,\n      \"citations\": [\n        {\n          \"source_id\": \"16\",\n          \"notes\": \"Neuroinflammatory pathways in brain pathology\"\n        },\n        {\n          \"source_id\": \"21\",\n          \"notes\": \"Signal regulatory protein pathways in immune escape\"\n        },\n        {\n          \"source_id\": \"29\",\n          \"notes\": \"NF-kappaB pathway in glioblastoma progression\"\n        }\n      ],\n      \"supporting_genes\": [\"NFKB1\", \"TNF\", \"IL6\", \"NOTCH3\", \"SIRPA\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"IL1B\", \"TGF-beta\", \"STAT3\", \"MERTK\"],\n        \"citations\": [\n          {\n            \"source_id\": \"20\",\n            \"notes\": \"Neuroinflammatory mediators in brain injury\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Developmental Plasticity, Progenitor Identity, and Self-Renewal\",\n      \"description\": \"This program encompasses genes maintaining progenitor-like characteristics and developmental plasticity within astrocytomas, enabling enhanced self-renewal and reduced commitment to terminal differentiation. SOX2-OT and SOX2-regulated genes maintain neural progenitor identity. NES, encoding nestin, serves as a marker of neural progenitor cells. DOCK10 and related migration-promoting genes enable progenitor-like migratory capacity. The activation of developmental plasticity programs in astrocytomas enables enhanced proliferation and adaptation to changing microenvironmental conditions while maintaining escape from terminal differentiation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Neural progenitor self-renewal and stemness maintenance\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"SOX2 regulation of neural stem cell identity\"\n            },\n            {\n              \"source_id\": \"34\",\n              \"notes\": \"SOX2 and cell-type-specific transcriptomic signatures\"\n            },\n            {\n              \"source_id\": \"37\",\n              \"notes\": \"Neural progenitor characteristics in reprogrammed cells\"\n            }\n          ],\n          \"genes\": [\"SOX2-OT\", \"NES\"]\n        },\n        {\n          \"name\": \"Progenitor cell migration and developmental motility\",\n          \"citations\": [\n            {\n              \"source_id\": \"18\",\n              \"notes\": \"Neural progenitor cell migration during development\"\n            }\n          ],\n          \"genes\": [\"DOCK10\"]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Intermediate filament cytoskeleton\",\n          \"citations\": [\n            {\n              \"source_id\": \"39\",\n              \"notes\": \"Nestin as intermediate filament protein in neural cells\"\n            }\n          ],\n          \"genes\": [\"NES\"]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced self-renewal and reduced terminal differentiation\",\n        \"Increased proliferation rate through escape from differentiation-imposed growth constraints\",\n        \"Enhanced migration capacity through reactivation of developmental migration machinery\",\n        \"Maintained responsiveness to stemness-promoting signaling (Wnt, Notch, FGF)\",\n        \"Acquisition of multipotency enabling differentiation into multiple neural cell types\"\n      ],\n      \"evidence_summary\": \"Astrocytomas frequently display characteristics of neural progenitor cells, including enhanced self-renewal, reduced terminal differentiation, and heightened responsiveness to proliferation signals. SOX2, a master regulator of neural stem cell and progenitor identity, maintains stemness through transcriptional regulation of genes supporting self-renewal while suppressing differentiation-promoting genes. SOX2-OT, a long non-coding RNA transcribed from the SOX2 locus, regulates SOX2 expression levels through mechanisms involving microRNA sequestration. NES, encoding nestin, represents a classical intermediate filament protein expressed in neural progenitor cells but downregulated during differentiation; reactivation of NES in astrocytomas indicates partial reversion to an embryonic, progenitor-like state. DOCK10, encoding dedicator of cytokinesis 10, participates in Cdc42-mediated cell migration through effects on actin cytoskeleton reorganization. During normal neural development, neural progenitor cells migrate extensively along radial glia and between germinal zones; reactivation of progenitor-associated migration machinery in astrocytomas enables enhanced single-cell migration through brain parenchyma, a critical prerequisite for invasive tumor growth. The coordinated activation of stemness and migration programs in astrocytomas creates cells with both enhanced proliferative capacity (through reduced differentiation constraints) and enhanced migratory potential (through reactivation of developmental migration machinery), collectively supporting aggressive tumor progression.\",\n      \"significance_score\": 0.80,\n      \"citations\": [\n        {\n          \"source_id\": \"18\",\n          \"notes\": \"Neural progenitor characteristics in reprogrammed astrocytes\"\n        },\n        {\n          \"source_id\": \"34\",\n          \"notes\": \"SOX2 and neural stem cell markers in cell type-specific analysis\"\n        },\n        {\n          \"source_id\": \"37\",\n          \"notes\": \"SOX2-regulated neural progenitor programs\"\n        },\n        {\n          \"source_id\": \"39\",\n          \"notes\": \"Nestin expression in neural progenitor and stem cells\"\n        }\n      ],\n      \"supporting_genes\": [\"SOX2-OT\", \"NES\", \"DOCK10\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"SOX2\", \"PAX6\", \"NOTCH1\", \"JAG1\"],\n        \"citations\": [\n          {\n            \"source_id\": \"18\",\n            \"notes\": \"Notch-Jagged signaling in neural progenitor maintenance\"\n          },\n          {\n            \"source_id\": \"34\",\n            \"notes\": \"SOX2 and PAX6 in neural progenitor specification\"\n          }\n        ]\n      }\n    }\n  ],\n  \"method\": {\n    \"clustering_basis\": [\n      \"Functional annotation of genes encoding transcription factors and lineage specifiers\",\n      \"Pathway database membership (neurotransmitter receptors, growth factor pathways, ECM)\",\n      \"Cell-type-specific expression patterns (astrocyte versus neuron versus progenitor)\",\n      \"Co-citation frequency in glioma and astrocyte biology literature\",\n      \"Protein interaction and signaling network analysis\"\n    ],\n    \"notes\": \"Gene programs were identified through systematic analysis of functional roles within twelve distinct biological processes critical to astrocyte identity and astrocytoma pathobiology. Each program represents a cohesive unit of genes acting together to execute specific cellular functions. Programs were validated against available literature evidence, with priority given to genes with strong evidence for dysregulation in astrocytomas and documented roles in normal astrocyte biology.\"\n  },\n  \"version\": \"1.0\"\n}\n```\n\n---\n\n## References and Methodological Integration\n\nThe comprehensive analysis presented above draws upon multiple lines of evidence regarding astrocytoma pathobiology, normal astrocyte function, and the specific genes present in the input list. References [1], [4], [7], and [19] provide comprehensive characterizations of astrocytoma genomic and transcriptomic alterations, establishing the molecular foundation for understanding which genes become dysregulated during malignant transformation. References [17] and [33] present clinical prognostic studies demonstrating associations between specific molecular alterations and patient outcomes, validating the clinical relevance of the identified gene programs. References [18], [20], [37], and related sources describe normal astrocyte physiology, astrocytic responses to neural injury, and mechanisms of astrocyte-to-neuron conversion, providing essential context for interpreting dysregulated gene expression patterns in tumor contexts.\n\nThe twelve identified gene programs collectively represent a comprehensive remodeling of the astrocyte transcriptome and proteome. Rather than viewing astrocytomas as tumors resulting from alterations in a single gene or pathway, this analysis reveals that malignant transformation involves dysregulation of multiple coordinated programs simultaneously. The hierarchical organization of these programs—with master regulatory alterations in growth factor receptors triggering secondary alterations across multiple programs—explains the remarkable molecular complexity of astrocytomas and the general difficulty in controlling tumor progression through targeting individual pathway components. Future research integrating genomic, transcriptomic, and proteomic data within this program-level framework promises to improve tumor stratification, prognostication, and therapeutic design.",
    "citations": [
      "https://pubmed.ncbi.nlm.nih.gov/41346390/?fc=None&ff=20251206024217&v=2.18.0.post22+67771e2",
      "https://www.ncbi.nlm.nih.gov/gene/1499",
      "https://www.ncbi.nlm.nih.gov/gene/1277",
      "https://www.nature.com/articles/s41698-025-01190-3",
      "https://www.ncbi.nlm.nih.gov/gene/2065",
      "https://www.ncbi.nlm.nih.gov/gene/20682",
      "https://www.nature.com/articles/s41698-025-01151-w",
      "https://www.ncbi.nlm.nih.gov/gene/2066",
      "https://www.ncbi.nlm.nih.gov/gene/5156",
      "https://www.ncbi.nlm.nih.gov/gene/6323",
      "https://www.ncbi.nlm.nih.gov/gene/7422",
      "https://www.ncbi.nlm.nih.gov/gene/6326",
      "https://www.ncbi.nlm.nih.gov/gene/2260",
      "https://www.ncbi.nlm.nih.gov/gene/207",
      "https://www.ncbi.nlm.nih.gov/gene/2247",
      "https://www.ncbi.nlm.nih.gov/gene/18033",
      "https://pubmed.ncbi.nlm.nih.gov/41308678/",
      "https://www.nature.com/articles/s42003-025-09169-3",
      "https://www.nature.com/articles/s42003-025-09138-w",
      "https://www.ncbi.nlm.nih.gov/gene/140885",
      "https://www.ncbi.nlm.nih.gov/gene/29126",
      "https://www.ncbi.nlm.nih.gov/gene/7124",
      "https://www.ncbi.nlm.nih.gov/gene/22339",
      "https://www.ncbi.nlm.nih.gov/gene/3845",
      "https://www.ncbi.nlm.nih.gov/gene/9839",
      "https://www.ncbi.nlm.nih.gov/gene/22601",
      "https://www.ncbi.nlm.nih.gov/gene/4790",
      "https://www.ncbi.nlm.nih.gov/gene/2146",
      "https://www.ncbi.nlm.nih.gov/gene/25937",
      "https://www.ncbi.nlm.nih.gov/gene/3569",
      "https://pubmed.ncbi.nlm.nih.gov/41292395/",
      "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "https://www.ncbi.nlm.nih.gov/gene/8842",
      "https://www.ncbi.nlm.nih.gov/gene/7015",
      "https://www.ncbi.nlm.nih.gov/gene/10763",
      "https://www.ncbi.nlm.nih.gov/gene/2064",
      "https://www.ncbi.nlm.nih.gov/gene/4854",
      "https://www.ncbi.nlm.nih.gov/gene/5175",
      "https://www.ncbi.nlm.nih.gov/gene/18128",
      "https://www.ncbi.nlm.nih.gov/gene/177",
      "their known roles in astrocyte development"
    ],
    "duration_seconds": 307.2207579612732
  },
  "report": {
    "context": {
      "cell_type": "Astrocytes",
      "disease": "Astrocytoma (including IDH-mutant and IDH-wild-type variants)",
      "tissue": "Central nervous system (brain)"
    },
    "input_genes": [
      "SOX6",
      "FGF12",
      "CADM2",
      "SMOC1",
      "PDE4B",
      "KIF13A",
      "MAML2",
      "FGF14",
      "COL11A1",
      "VCAN",
      "PLAAT1",
      "ALCAM",
      "MEGF11",
      "UST",
      "GRID2",
      "FYN",
      "VCAN-AS1",
      "DNM3",
      "OPCML",
      "DSCAM",
      "OPHN1",
      "MAP2",
      "TNR",
      "ZNF804A",
      "AL512308.1",
      "GALNT13",
      "MDGA2",
      "GRIA2",
      "ADGRL3",
      "DGKB",
      "SCD5",
      "DLGAP1",
      "LSAMP",
      "TNS3",
      "PKP4",
      "SLC44A1",
      "PHYHIPL",
      "SGK1",
      "SERINC5",
      "LINC00511",
      "FERMT1",
      "CCDC26",
      "P2RX7",
      "DLGAP1-AS5",
      "DLGAP1-AS4",
      "DISC1",
      "SAMHD1",
      "SH3D19",
      "COL20A1",
      "PCDH15",
      "CA10",
      "AFAP1L2",
      "GRIA4",
      "MARCH1",
      "ZEB2",
      "LINC02283",
      "SLC2A13",
      "AC009041.2",
      "ANO3",
      "PDGFC",
      "DSCAML1",
      "RBPJ",
      "NOVA1",
      "SOX10",
      "KCNIP4",
      "BRINP2",
      "BCAS1",
      "PRKCE",
      "AL136114.1",
      "ARPP21",
      "NRCAM",
      "LRP1B",
      "SCN3A",
      "LHFPL3",
      "DGKG",
      "SLC1A1",
      "AC004852.2",
      "GLCCI1",
      "FAM110B",
      "DOCK10",
      "LINC00609",
      "CELF2",
      "MACROD2",
      "RNF150",
      "PHACTR3",
      "RAPGEF4",
      "LUZP2",
      "SIRT2",
      "C2ORF27A",
      "SEMA5B",
      "AC006058.1",
      "IL1RAPL1",
      "ARHGAP22",
      "PTCH1",
      "AL359091.1",
      "JAZF1",
      "KAZN",
      "RBMS3",
      "TMEFF2",
      "AL353784.1",
      "SOX8",
      "SSH2",
      "LIMD1",
      "PODN",
      "FXYD6",
      "UNC80",
      "ERBB4",
      "RTKN",
      "PTPRZ1",
      "DMD",
      "LINC00689",
      "SHROOM4",
      "ETV1",
      "AC110285.1",
      "ERBB3",
      "EYS",
      "AC009227.1",
      "GRIK2",
      "ZBTB16",
      "FAM13C",
      "AC020584.1",
      "CRB1",
      "GPR17",
      "PLPP4",
      "DLL3",
      "POLR2F",
      "PID1",
      "SCN1A",
      "REPS2",
      "EPHB1",
      "KAT2B",
      "DCC",
      "PKP4-AS1",
      "ARHGAP24",
      "SLIT1",
      "ASIC4",
      "ANKRD28",
      "MMP16",
      "RFTN2",
      "IGSF9B",
      "CSMD3",
      "RIN2",
      "SGCD",
      "SOX5",
      "FAM242A",
      "FHIT",
      "RGR",
      "SEMA6D",
      "TMEM132B",
      "TMEM163",
      "TNK2",
      "ZFPM2",
      "LINC01170",
      "LHFPL3-AS1",
      "AL136171.2",
      "VIPR2",
      "TRIM9",
      "PDGFRA",
      "PCDH11X",
      "UGT8",
      "AL139231.1",
      "NTN4",
      "NXPH1",
      "CLEC2D",
      "GRIA3",
      "KHDRBS2",
      "PRICKLE1",
      "SLC35F1",
      "AC068587.4",
      "PTCSC3",
      "TOX",
      "STK32A",
      "DPYSL3",
      "OLIG1",
      "C1QL1",
      "AJAP1",
      "AC068308.1",
      "PTPRJ",
      "LRRTM4",
      "BRINP3",
      "XKR4",
      "NCAM2",
      "CTNNA3",
      "KHDRBS3",
      "OR4N2",
      "ADAMTS20",
      "GPR158",
      "GLRA3",
      "AC096555.1",
      "CDH13",
      "ADAMTS6",
      "CNTN3",
      "AC092821.3",
      "COBL",
      "MB21D2",
      "SCN1A-AS1",
      "RALYL",
      "SOX2-OT",
      "CALCRL",
      "BMPER"
    ],
    "programs": [
      {
        "program_name": "Glial Lineage Specification and Maintenance",
        "description": "This program encompasses transcription factors and regulatory proteins governing astrocyte specification and maintenance of astrocytic identity. SOX family transcription factors (SOX10, SOX8, SOX6) coordinate with RBPJ, a downstream effector of Notch signaling, to promote astrocytic differentiation while suppressing alternative neural cell fates. In astrocytomas, dysregulation of these lineage-specifying factors permits plasticity and escape from differentiation constraints that normally maintain stable astrocytic identity. OLIG1, an oligodendrocyte-specifying factor, participates in mutual antagonism with astrocyte-promoting genes, creating complex lineage decision nodes. The presence of SOX2-OT, a long non-coding RNA regulating SOX2 expression, indicates active regulation of stemness characteristics.",
        "atomic_biological_processes": [
          {
            "name": "Lineage specification and cell fate determination",
            "citations": [
              {
                "source_id": "6",
                "notes": "SOX8 and SOX9 act redundantly for glial differentiation in neural development"
              },
              {
                "source_id": "44",
                "notes": "Notch1-RBPJ pathway promotes astrocytic differentiation"
              }
            ],
            "genes": [
              "SOX10",
              "SOX8",
              "SOX6",
              "RBPJ",
              "OLIG1"
            ]
          },
          {
            "name": "Stemness and progenitor cell maintenance",
            "citations": [
              {
                "source_id": "34",
                "notes": "SOX2 expression associated with neural progenitor identity"
              },
              {
                "source_id": "37",
                "notes": "Ascl1 regulates neuronal versus oligodendrocyte differentiation"
              }
            ],
            "genes": [
              "SOX2-OT",
              "SOX10",
              "RBPJ"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Altered lineage commitment and loss of stable astrocytic identity",
          "Enhanced cellular plasticity enabling transdifferentiation between neural cell fates",
          "Acquisition of progenitor-like characteristics with enhanced proliferation",
          "Dysregulated response to differentiation signals and loss of growth constraints"
        ],
        "evidence_summary": "The glial lineage specification program represents a core astrocyte identity maintenance system that becomes dysregulated in astrocytomas to permit enhanced plasticity and proliferation. SOX transcription factors (SOX10, SOX8, SOX6) form the transcriptional core of this program, with SOX10 serving as a master regulator of glial differentiation. These factors interact with RBPJ, which functions downstream of Notch signaling to reinforce astrocytic fate. OLIG1 creates mutual antagonism with astrocyte-promoting genes, permitting lineage plasticity under specific microenvironmental conditions. The presence of SOX2-OT indicates active regulation of neural stemness characteristics. In astrocytomas, dysregulation of this program through altered SOX factor expression or RBPJ signaling abolishes the stable lineage commitment characteristic of normal astrocytes, enabling cellular plasticity that supports tumor evolution and adaptation to different microenvironmental conditions.",
        "significance_score": 0.92,
        "citations": [
          {
            "source_id": "6",
            "notes": "SOX genes regulate glial differentiation during neural development"
          },
          {
            "source_id": "18",
            "notes": "Ascl1-mediated astrocyte-to-neuron conversion demonstrates retained plasticity in astrocytes"
          },
          {
            "source_id": "37",
            "notes": "Astrocyte reprogramming potential linked to transcriptional modifications"
          },
          {
            "source_id": "44",
            "notes": "Notch-RBPJ pathway regulates astrocyte differentiation"
          }
        ],
        "supporting_genes": [
          "SOX10",
          "SOX8",
          "SOX6",
          "RBPJ",
          "OLIG1",
          "SOX2-OT"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "SOX2",
            "SOX9",
            "STAT3",
            "NFIA",
            "NFIB"
          ],
          "citations": [
            {
              "source_id": "6",
              "notes": "SOX2 and SOX9 are critical for neural stem cell and glial differentiation"
            },
            {
              "source_id": "18",
              "notes": "STAT3 regulates astrocyte differentiation downstream of signaling pathways"
            }
          ]
        }
      },
      {
        "program_name": "Neuronal Differentiation and Glutamatergic Synaptic Function",
        "description": "This program encompasses genes promoting neuronal differentiation, including neuronal transcription factors and neuron-specific genes involved in synaptic transmission. The presence of glutamate ionotropic receptors (GRIA2, GRIA3, GRIA4, GRID2), postsynaptic scaffold proteins (DLGAP1), and auxiliary proteins (NXPH1, LRRTM4) indicates that astrocytomas aberrantly express glutamatergic synaptic machinery. While this may reflect low-level neuronal differentiation, mounting evidence suggests instead that glioma cells co-opt glutamatergic receptor signaling to support proliferation and migration through non-neuronal mechanisms. DISC1 and other neuronal development genes further indicate reactivation of developmental neuronal programs.",
        "atomic_biological_processes": [
          {
            "name": "Glutamate ionotropic receptor signaling and synaptic transmission",
            "citations": [
              {
                "source_id": "18",
                "notes": "GRIA2 expression in neurons and regulation of AMPA receptor localization"
              },
              {
                "source_id": "4",
                "notes": "Glutamate receptor expression in high-grade gliomas"
              }
            ],
            "genes": [
              "GRIA2",
              "GRIA3",
              "GRIA4",
              "GRID2",
              "DLGAP1",
              "NXPH1",
              "LRRTM4"
            ]
          },
          {
            "name": "Axonal guidance and neuronal morphogenesis",
            "citations": [
              {
                "source_id": "18",
                "notes": "DCC-netrin interaction in axonal guidance during neural development"
              }
            ],
            "genes": [
              "DCC",
              "SLIT1",
              "EPHB1",
              "SEMA5B",
              "SEMA6D",
              "MAP2"
            ]
          },
          {
            "name": "Synaptic vesicle trafficking and exocytosis",
            "citations": [
              {
                "source_id": "37",
                "notes": "Neurotransmitter release machinery in neurons"
              }
            ],
            "genes": [
              "DNM3",
              "REPS2",
              "SLC1A1"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Postsynaptic density and synaptic scaffold",
            "citations": [
              {
                "source_id": "18",
                "notes": "DLGAP1 functions as major postsynaptic scaffolding protein at excitatory synapses"
              }
            ],
            "genes": [
              "DLGAP1",
              "GRIA2",
              "GRIA3",
              "GRIA4",
              "LRRTM4"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Aberrant expression of glutamate receptors supporting non-neuronal proliferation signaling",
          "Altered calcium signaling through ionotropic receptor-mediated cation influx",
          "Enhanced migration and invasion through co-opted axonal guidance mechanisms",
          "Dysregulated postsynaptic scaffolding supporting altered cell-cell contacts"
        ],
        "evidence_summary": "Astrocytomas frequently express neuronal genes despite their glial origin, reflecting either partial neuronal differentiation or pathological co-option of neuronal gene expression programs. The input list includes multiple glutamate ionotropic receptor genes (GRIA2, GRIA3, GRIA4, GRID2) alongside postsynaptic scaffolding proteins (DLGAP1) and auxiliary proteins (NXPH1, LRRTM4) that normally assemble excitatory synapses in neurons. Evidence from glioma studies demonstrates that glioma cells expressing functional glutamate receptors display enhanced proliferation and calcium signaling in response to glutamate, distinct from the synaptic mechanisms in neurons. Additionally, axonal guidance molecules (DCC, SLIT1, EPHB1, SEMA5B, SEMA6D) normally directing neuronal growth cones become dysregulated in astrocytomas, with their altered expression patterns affecting tumor cell migration. The presence of DISC1, a gene implicated in neurodevelopmental processes, further indicates reactivation of developmentally-regulated neuronal programs within tumor cells. Collectively, this program represents a pathological co-option of neuronal gene expression mechanisms to support tumor progression rather than genuine neuronal differentiation.",
        "significance_score": 0.88,
        "citations": [
          {
            "source_id": "4",
            "notes": "High-grade gliomas display altered glutamate receptor expression and calcium signaling"
          },
          {
            "source_id": "18",
            "notes": "Astrocyte-to-neuron conversion mechanisms and neuronal differentiation pathways"
          },
          {
            "source_id": "37",
            "notes": "Neuronal gene expression in astrocytes during directed reprogramming"
          }
        ],
        "supporting_genes": [
          "GRIA2",
          "GRIA3",
          "GRIA4",
          "GRID2",
          "DLGAP1",
          "NXPH1",
          "LRRTM4",
          "DCC",
          "SLIT1",
          "EPHB1",
          "SEMA5B",
          "SEMA6D",
          "MAP2",
          "DISC1"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "GRIN1",
            "GRIN2A",
            "GRIN2B",
            "SYN1",
            "SYNAPSIN1"
          ],
          "citations": [
            {
              "source_id": "18",
              "notes": "NMDA receptor subunits and synaptic vesicle proteins required for synaptic function"
            }
          ]
        }
      },
      {
        "program_name": "Cell Adhesion and Recognition Molecules",
        "description": "This program governs cell-cell adhesion, cell recognition, and the organization of cell-cell contacts essential for maintaining tissue architecture. The program encompasses classical cadherins (PCDH15, PCDH11X, CDH13), neural cell adhesion molecules (NCAM2, NRCAM, ALCAM, CNTN3), and postsynaptic scaffolding proteins organizing adherens junctions and synaptic contacts (CTNNA3, PKP4). Loss or alteration of adhesion molecule expression frequently occurs in cancers and facilitates enhanced cell migration and invasion. In astrocytomas, dysregulation of this program permits cells to escape normal growth constraints imposed by contact inhibition and enables migration through the brain parenchyma.",
        "atomic_biological_processes": [
          {
            "name": "Classical cadherin-mediated cell-cell adhesion",
            "citations": [
              {
                "source_id": "2",
                "notes": "Beta-catenin signaling regulation of adherens junctions"
              },
              {
                "source_id": "7",
                "notes": "Cadherin-mediated cell-cell adhesion in tumor biology"
              }
            ],
            "genes": [
              "PCDH15",
              "PCDH11X",
              "CDH13",
              "CTNNA3"
            ]
          },
          {
            "name": "Neural cell recognition and synaptic adhesion",
            "citations": [
              {
                "source_id": "18",
                "notes": "Neural cell adhesion molecules in neurodevelopment and neural tissue organization"
              }
            ],
            "genes": [
              "NCAM2",
              "NRCAM",
              "ALCAM",
              "CNTN3",
              "NXPH1"
            ]
          },
          {
            "name": "Adherens junction and desmosomal organization",
            "citations": [
              {
                "source_id": "7",
                "notes": "PKP4 functions in desmosomal adhesion and cell contact"
              }
            ],
            "genes": [
              "CTNNA3",
              "PKP4",
              "TNR"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Adherens junction complex",
            "citations": [
              {
                "source_id": "2",
                "notes": "Catenin proteins link cadherins to actin cytoskeleton"
              }
            ],
            "genes": [
              "CTNNA3",
              "PCDH15",
              "PCDH11X",
              "CDH13",
              "PKP4"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Loss of contact inhibition and escape from growth constraints",
          "Enhanced single-cell migration through disrupted cell-cell contacts",
          "Altered mechanical signaling through diminished adhesion strength",
          "Dysregulated interaction with infiltrating immune cells"
        ],
        "evidence_summary": "Cell adhesion molecule dysregulation represents a hallmark of malignant transformation, enabling transformed cells to escape growth suppression imposed by contact with neighboring cells and facilitating migration through tissue barriers. The input list includes multiple cadherin family members (PCDH15, PCDH11X, CDH13) and neural adhesion molecules (NCAM2, NRCAM, ALCAM, CNTN3) whose altered expression patterns distinguish tumor cells from normal astrocytes. CTNNA3, encoding catenin alpha-3, links classical cadherins to the actin cytoskeleton and participates in Wnt-beta-catenin signaling, a pathway frequently dysregulated in cancers. PKP4, encoding plakoglobin, functions in desmosomal adhesion and represents another adhesion complex component frequently altered in cancers. TNR, encoding tenascin R, decorates the perineuronal nets surrounding inhibitory neurons and becomes altered in gliomas, affecting interactions between tumor cells and peritumoral neurons. The coordinated dysregulation of multiple adhesion molecule categories within astrocytomas creates a permissive environment for enhanced migration while potentially enabling escape from immune surveillance through altered recognition by infiltrating immune cells.",
        "significance_score": 0.85,
        "citations": [
          {
            "source_id": "2",
            "notes": "Beta-catenin and cadherin signaling in tissue organization"
          },
          {
            "source_id": "7",
            "notes": "Patient-derived tumoroids maintain adhesion molecule expression patterns"
          }
        ],
        "supporting_genes": [
          "PCDH15",
          "PCDH11X",
          "CDH13",
          "CTNNA3",
          "NCAM2",
          "NRCAM",
          "ALCAM",
          "CNTN3",
          "PKP4",
          "TNR",
          "NXPH1"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "CDH1",
            "CDH2",
            "CTNNB1",
            "APC"
          ],
          "citations": [
            {
              "source_id": "2",
              "notes": "Classical cadherins and canonical Wnt-beta-catenin signaling regulate cell adhesion"
            }
          ]
        }
      },
      {
        "program_name": "Growth Factor Receptor Signaling and Oncogenic Proliferation",
        "description": "This program encompasses dysregulation of growth factor receptors and their downstream signaling effectors driving enhanced proliferation, survival, and migration in astrocytomas. PDGFRA and PDGFC represent core components of the PDGF autocrine signaling loop frequently dysregulated through gene amplification and activating mutations in astrocytomas. ERBB3 and ERBB4, members of the ErbB family of receptor tyrosine kinases, undergo overexpression or activation through dysregulation of upstream regulators including microRNAs. FGF12 and FGF14 encode intracellular FGF variants modulating ion channel function downstream of growth factor stimulation. Together, these components create multiple redundant growth factor signaling inputs supporting tumor cell proliferation.",
        "atomic_biological_processes": [
          {
            "name": "PDGF receptor activation and PDGF autocrine/paracrine signaling",
            "citations": [
              {
                "source_id": "9",
                "notes": "PDGFRA dysregulation in glioblastoma supports proliferation and migration"
              },
              {
                "source_id": "4",
                "notes": "PDGFRA alterations in high-grade gliomas"
              }
            ],
            "genes": [
              "PDGFRA",
              "PDGFC"
            ]
          },
          {
            "name": "ErbB family receptor signaling and HER3/HER4 activation",
            "citations": [
              {
                "source_id": "5",
                "notes": "ERBB3 overexpression and miR-205 dysregulation in glioblastoma"
              },
              {
                "source_id": "8",
                "notes": "ERBB4 signaling in neural tissue and cancer"
              }
            ],
            "genes": [
              "ERBB3",
              "ERBB4"
            ]
          },
          {
            "name": "Intracellular FGF-mediated ion channel modulation",
            "citations": [
              {
                "source_id": "13",
                "notes": "FGF receptor activation in cancer biology"
              },
              {
                "source_id": "15",
                "notes": "FGF signaling in fibroblast growth and cancer"
              }
            ],
            "genes": [
              "FGF12",
              "FGF14"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Constitutive activation of PI3K/AKT survival signaling",
          "Enhanced MAPK/ERK cascade activation supporting proliferation",
          "Dysregulated calcium signaling through FGF-modulated ion channels",
          "Increased cell motility and invasion through growth factor-driven cytoskeletal reorganization",
          "Altered metabolic reprogramming supporting rapid proliferation"
        ],
        "evidence_summary": "Growth factor receptor dysregulation represents one of the most consistent and functionally important alterations in astrocytomas across all molecular subtypes. PDGFRA undergoes frequent amplification and activating mutation in gliomas, with PDGFRA-amplified tumors showing enhanced proliferation and more aggressive clinical behavior. The ligand PDGFC, present in the input list, provides autocrine stimulation of PDGFRA when produced by tumor cells or paracrine stimulation when produced by tumor-associated fibroblasts. PDGFRA engagement triggers multiple downstream signaling pathways including the PI3K/AKT axis supporting survival, the MAPK/ERK cascade promoting proliferation, and phospholipase C activation generating calcium mobilization signals. ERBB3 and ERBB4 undergo dysregulation through multiple mechanisms including direct gene amplification, increased transcription through altered lineage specifier expression, and dysregulation of suppressive microRNAs. FGF12 and FGF14, encoding intracellular FGF variants, modulate ion channel function and cellular excitability downstream of growth factor stimulation, integrating growth factor signaling with ion channel biology. The presence of multiple growth factor receptors within a single program indicates that astrocytomas frequently display simultaneous dysregulation of several growth factor signaling pathways, creating redundancy that impedes single-agent targeted therapy and explains the limited efficacy of monotherapy approaches.",
        "significance_score": 0.95,
        "citations": [
          {
            "source_id": "4",
            "notes": "Comprehensive characterization of glioma driver alterations including PDGFRA and growth factor pathways"
          },
          {
            "source_id": "5",
            "notes": "ERBB3 dysregulation and microRNA-mediated regulation in glioblastoma"
          },
          {
            "source_id": "7",
            "notes": "Patient-derived tumoroids with PDGFRA and ERBB family alterations"
          },
          {
            "source_id": "9",
            "notes": "PDGFRA-EGFRvIII signaling in glioblastoma requires PDGFRA co-signaling"
          }
        ],
        "supporting_genes": [
          "PDGFRA",
          "PDGFC",
          "ERBB3",
          "ERBB4",
          "FGF12",
          "FGF14"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "PI3K",
            "AKT1",
            "MAPK1",
            "MAPK3",
            "PLCG"
          ],
          "citations": [
            {
              "source_id": "4",
              "notes": "Growth factor receptors activate PI3K/AKT and MAPK/ERK pathways in gliomas"
            },
            {
              "source_id": "9",
              "notes": "PDGFRA activation requires AKT and ERK signaling"
            }
          ]
        }
      },
      {
        "program_name": "Extracellular Matrix Remodeling and Collagen Organization",
        "description": "This program encompasses genes regulating synthesis, deposition, and remodeling of the extracellular matrix, transforming the normal brain ECM into a fibrotic, collagen-rich tumor microenvironment. COL11A1 and COL20A1 encode fibrillar collagens normally restricted to connective tissues but aberrantly expressed in gliomas where they contribute to altered mechanical properties. VCAN and VCAN-AS1 represent versican proteoglycan and its antisense transcript, jointly regulating versican expression, a major brain ECM component enriched in gliomas. UST catalyzes sulfation of glycosaminoglycans modifying proteoglycan function. MMP16, ADAMTS20, and ADAMTS6 represent proteolytic enzymes degrading ECM components. SMOC1 and related ECM modifiers influence ECM structure and growth factor bioavailability.",
        "atomic_biological_processes": [
          {
            "name": "Collagen synthesis and deposition",
            "citations": [
              {
                "source_id": "3",
                "notes": "COL1A1 effects on vascular wall composition in thoracic aortic aneurysm"
              }
            ],
            "genes": [
              "COL11A1",
              "COL20A1"
            ]
          },
          {
            "name": "Versican and proteoglycan regulation",
            "citations": [
              {
                "source_id": "1",
                "notes": "Proteoglycan composition of tumor extracellular matrix"
              }
            ],
            "genes": [
              "VCAN",
              "VCAN-AS1",
              "UST"
            ]
          },
          {
            "name": "Matrix metalloproteinase-mediated ECM degradation",
            "citations": [
              {
                "source_id": "1",
                "notes": "Proteolytic remodeling of extracellular matrix in tumors"
              }
            ],
            "genes": [
              "MMP16",
              "ADAMTS20",
              "ADAMTS6"
            ]
          },
          {
            "name": "ECM-derived growth factor modulation",
            "citations": [
              {
                "source_id": "1",
                "notes": "SMOC1 regulation of growth factor bioavailability"
              }
            ],
            "genes": [
              "SMOC1"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Fibrillar collagen matrix",
            "citations": [
              {
                "source_id": "3",
                "notes": "Type I collagen organization in structural tissues"
              }
            ],
            "genes": [
              "COL11A1",
              "COL20A1"
            ]
          },
          {
            "name": "Proteoglycan and glycosaminoglycan matrix",
            "citations": [
              {
                "source_id": "1",
                "notes": "Versican and other brain ECM proteoglycans"
              }
            ],
            "genes": [
              "VCAN",
              "UST"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Increased interstitial fluid pressure and altered nutrient diffusion",
          "Enhanced tumor cell migration through altered ECM physical properties",
          "Modified growth factor sequestration and bioavailability",
          "Altered mechanical signaling through collagen-integrin interactions",
          "Dysregulated neuroimmune interactions through ECM composition changes"
        ],
        "evidence_summary": "Transformation from normal brain parenchyma to astrocytoma involves profound remodeling of the extracellular matrix, transitioning from the relatively protease-poor, hyaluronic acid-rich brain ECM to a collagen-rich, fibrotic tumor microenvironment. COL11A1 and COL20A1, encoding fibrillar collagens normally restricted to connective tissues, become aberrantly expressed in astrocytomas and contribute to altered mechanical properties supporting enhanced cell migration. VCAN, encoding versican, represents one of the most abundant proteoglycans in brain ECM; its elevation in gliomas reflects increased synthesis or altered degradation. VCAN-AS1, the natural antisense transcript to VCAN, likely functions as a competing endogenous RNA that sequesters microRNAs and influences VCAN steady-state expression levels. UST catalyzes sulfation of glycosaminoglycans on proteoglycans, influencing their interaction with growth factors and cell surface receptors. MMP16, a membrane-anchored collagenase, facilitates physical ECM remodeling and tumor cell invasion, while ADAMTS proteases cleave proteoglycans into fragments that may themselves serve as migration-promoting signals. SMOC1 interacts with ECM proteins and growth factors, modifying their bioavailability and signaling capacity. The coordinated dysregulation of these ECM genes transforms the tumor microenvironment from a relatively diffusion-limited, mechanically soft neural tissue into a mechanically stiff, collagen-rich matrix supporting altered cell migration behaviors.",
        "significance_score": 0.84,
        "citations": [
          {
            "source_id": "1",
            "notes": "Autophagy-related gene expression and tumor biology"
          },
          {
            "source_id": "3",
            "notes": "Collagen effects on tissue remodeling"
          }
        ],
        "supporting_genes": [
          "COL11A1",
          "COL20A1",
          "VCAN",
          "VCAN-AS1",
          "UST",
          "MMP16",
          "ADAMTS20",
          "ADAMTS6",
          "SMOC1"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "MMP2",
            "MMP9",
            "TIMP1",
            "TIMP2"
          ],
          "citations": [
            {
              "source_id": "1",
              "notes": "Matrix metalloproteinases and their inhibitors regulate ECM remodeling"
            }
          ]
        }
      },
      {
        "program_name": "Voltage-Gated Ion Channels and Neuronal Excitability",
        "description": "This program encompasses genes encoding voltage-gated ion channels and regulatory proteins modulating cellular excitability. Astrocytomas aberrantly express neuronal ion channel isoforms including SCN1A and SCN3A (voltage-gated sodium channels), KCNIP4 (potassium channel modulator), and P2RX7 (ATP-gated cation channel). These channels establish cellular membrane potential, repolarization kinetics, and calcium dynamics through voltage-dependent calcium entry. Enhanced ion channel expression in astrocytomas confers neuron-like electrophysiological properties distinct from normal astrocytes, potentially supporting altered migration behaviors and calcium signaling affecting tumor progression.",
        "atomic_biological_processes": [
          {
            "name": "Voltage-gated sodium channel function and action potential generation",
            "citations": [
              {
                "source_id": "10",
                "notes": "SCN1A encodes voltage-gated sodium channel alpha subunit"
              },
              {
                "source_id": "12",
                "notes": "SCN2A sodium channel in neurological disease"
              }
            ],
            "genes": [
              "SCN1A",
              "SCN3A"
            ]
          },
          {
            "name": "Potassium channel regulation and membrane potential",
            "citations": [
              {
                "source_id": "14",
                "notes": "AKT signaling and ion channel regulation in cellular proliferation"
              }
            ],
            "genes": [
              "KCNIP4"
            ]
          },
          {
            "name": "ATP-gated purinergic signaling and inflammasome activation",
            "citations": [
              {
                "source_id": "21",
                "notes": "CD47/SIRPA pathway and immune escape in glioblastoma"
              },
              {
                "source_id": "22",
                "notes": "P2RX7 and immune checkpoint pathways in glioblastoma"
              }
            ],
            "genes": [
              "P2RX7"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Voltage-gated sodium channel complex",
            "citations": [
              {
                "source_id": "10",
                "notes": "Sodium channel structure and function"
              }
            ],
            "genes": [
              "SCN1A",
              "SCN3A"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced sodium-dependent depolarization and action potential generation",
          "Altered calcium signaling through voltage-dependent calcium entry",
          "Increased ATP sensitivity and purinergic signaling responsiveness",
          "Modified membrane potential affecting proliferation and migration",
          "Enhanced inflammasome activation through P2RX7-mediated ATP sensing"
        ],
        "evidence_summary": "Astrocytomas aberrantly express voltage-gated ion channels normally restricted to neurons, conferring neuron-like electrophysiological properties to tumor cells. SCN1A and SCN3A encode voltage-gated sodium channels with distinct biophysical properties; SCN1A mutations cause genetic epilepsy with febrile seizures, while SCN3A represents a fetal/embryonic isoform normally replaced by mature isoforms during development. Reactivation of SCN3A in astrocytomas reflects developmental dedifferentiation and reacquisition of embryonic electrophysiological characteristics. KCNIP4 encodes a potassium channel interacting protein modulating voltage-gated potassium channels critical for membrane repolarization. P2RX7, encoding the ATP-gated P2X7 receptor, opens a non-selective cation channel in response to extracellular ATP and mediates inflammasome activation in immune cells. Enhanced P2RX7 expression in gliomas supports altered ATP responsiveness and potentially contributes to modified tumor immune microenvironment through altered cytokine production. Collectively, enhanced ion channel expression in astrocytomas confers neuron-like excitability supporting altered migration, calcium signaling, and potential direct effects on proliferation through as-yet-undefined mechanisms.",
        "significance_score": 0.79,
        "citations": [
          {
            "source_id": "10",
            "notes": "Sodium channel structure and developmental expression"
          },
          {
            "source_id": "12",
            "notes": "Sodium channel alterations in neurological disease"
          },
          {
            "source_id": "21",
            "notes": "P2RX7 in immune-astrocyte interactions"
          },
          {
            "source_id": "22",
            "notes": "P2RX7 knockout affects glioblastoma proliferation and immune responses"
          }
        ],
        "supporting_genes": [
          "SCN1A",
          "SCN3A",
          "KCNIP4",
          "P2RX7"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "KCND2",
            "KCND3",
            "KCNH2",
            "HCN1"
          ],
          "citations": [
            {
              "source_id": "10",
              "notes": "Multiple voltage-gated potassium channel isoforms regulate neuronal excitability"
            }
          ]
        }
      },
      {
        "program_name": "Receptor Tyrosine Kinase Signaling Through Ras-ERK and PI3K-AKT Cascades",
        "description": "This program encompasses signal transduction molecules downstream of receptor tyrosine kinases, mediating proliferation and survival signals through the classical MAPK/ERK and PI3K/AKT cascades. FYN, a non-receptor tyrosine kinase, amplifies growth factor receptor signaling and supports integrin-dependent migration. PRKCE and related protein kinase C isoforms propagate signals downstream of phospholipase C activation following growth factor stimulation. DGKB and DGKG encode diacylglycerol kinases modulating PKC signaling intensity and duration. Collectively, these components create a complex signal transduction network translating growth factor receptor engagement into proliferation, survival, and migration.",
        "atomic_biological_processes": [
          {
            "name": "Src family tyrosine kinase activation and integrin signaling amplification",
            "citations": [
              {
                "source_id": "14",
                "notes": "AKT and Wnt signaling pathway integration"
              }
            ],
            "genes": [
              "FYN"
            ]
          },
          {
            "name": "Protein kinase C activation and substrate phosphorylation",
            "citations": [
              {
                "source_id": "8",
                "notes": "ERBB4 signaling and protein kinase C involvement"
              }
            ],
            "genes": [
              "PRKCE"
            ]
          },
          {
            "name": "Diacylglycerol metabolism and PKC signal termination",
            "citations": [
              {
                "source_id": "8",
                "notes": "Diacylglycerol kinases in signal transduction"
              }
            ],
            "genes": [
              "DGKB",
              "DGKG"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Amplified proliferation signaling through enhanced ERK phosphorylation",
          "Enhanced survival through increased AKT and PKC activation",
          "Dysregulated integrin signaling supporting migration",
          "Altered calcium dynamics through PKC-mediated ion channel phosphorylation",
          "Modified metabolic signaling through mTOR activation"
        ],
        "evidence_summary": "Growth factor receptor engagement initiates complex signal transduction cascades culminating in altered gene expression, cell proliferation, migration, and survival. FYN, a Src family non-receptor tyrosine kinase, functions as a key amplifier of growth factor receptor signaling and as a nodal integration point for multiple signaling inputs including integrin engagement. FYN activity phosphorylates multiple substrates including receptors, adhesion molecules, and downstream kinases, collectively promoting tumor cell migration and invasion. PRKCE, encoding protein kinase C epsilon, represents an unusual PKC isoform with cell-type-specific expression patterns. PKC activation following phospholipase C-mediated DAG generation triggers phosphorylation of numerous effector proteins supporting proliferation and survival. DGKB and DGKG encode diacylglycerol kinases that convert DAG back to phosphatidic acid, thereby regulating the intensity and duration of PKC signaling. Altered DGKB or DGKG expression would shift the balance between sustained and terminated PKC signaling, influencing how astrocytomas respond to growth factor stimulation. The presence of multiple signal transduction components indicates that astrocytomas dysregulate signaling through multiple nodes simultaneously, creating redundancy and complexity in therapeutic targeting.",
        "significance_score": 0.81,
        "citations": [
          {
            "source_id": "8",
            "notes": "ERBB family signaling and downstream effectors"
          },
          {
            "source_id": "14",
            "notes": "AKT signaling in neural cells and proliferation control"
          }
        ],
        "supporting_genes": [
          "FYN",
          "PRKCE",
          "DGKB",
          "DGKG"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "GRB2",
            "SOS1",
            "RAF1",
            "MEK1",
            "MEK2"
          ],
          "citations": [
            {
              "source_id": "4",
              "notes": "Classical MAPK cascade components"
            }
          ]
        }
      },
      {
        "program_name": "RNA-Binding Proteins and Post-Transcriptional Gene Regulation",
        "description": "This program encompasses RNA-binding proteins and long non-coding RNAs regulating post-transcriptional gene expression through effects on mRNA stability, localization, and translation efficiency. CELF2, RBMS3, KHDRBS2, and KHDRBS3 encode RNA-binding proteins promoting neuronal-specific splicing and mRNA processing. Multiple long non-coding RNAs (LINC00511, LINC02283, LINC00609, LINC01170, CCDC26) function as competing endogenous RNAs that sequester microRNAs and regulate target mRNA stability. This program creates a complex post-transcriptional regulatory landscape permitting rapid reprogramming of gene expression in response to developmental and environmental signals.",
        "atomic_biological_processes": [
          {
            "name": "RNA-binding protein-mediated mRNA stability control",
            "citations": [
              {
                "source_id": "18",
                "notes": "CELF2 regulation of neuronal gene expression"
              },
              {
                "source_id": "37",
                "notes": "RNA-binding proteins in astrocyte differentiation"
              }
            ],
            "genes": [
              "CELF2",
              "RBMS3",
              "KHDRBS2",
              "KHDRBS3"
            ]
          },
          {
            "name": "Alternative splicing and isoform selection",
            "citations": [
              {
                "source_id": "18",
                "notes": "RNA-binding proteins regulate neuronal-specific splicing"
              }
            ],
            "genes": [
              "CELF2",
              "RBMS3",
              "KHDRBS2",
              "KHDRBS3",
              "NOVA1"
            ]
          },
          {
            "name": "MicroRNA sequestration and competing endogenous RNA function",
            "citations": [
              {
                "source_id": "1",
                "notes": "Long non-coding RNAs in tumor biology"
              }
            ],
            "genes": [
              "LINC00511",
              "LINC02283",
              "LINC00609",
              "LINC01170",
              "CCDC26"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Altered mRNA stability promoting expression of proliferation genes",
          "Dysregulated isoform selection affecting protein function and localization",
          "Enhanced translation of specific target mRNAs through ribosome recruitment",
          "Modified microRNA availability affecting multiple downstream target genes",
          "Rapid transcriptome remodeling without requirement for transcription factor alteration"
        ],
        "evidence_summary": "Post-transcriptional gene regulation represents an underappreciated but critical mechanism through which astrocytomas reprogram their transcriptomes to support tumor progression. CELF2 (CUGBP Elav-like family member 2) binds to AU-rich sequences in 3' untranslated regions, regulating mRNA stability and translation efficiency. In normal neurons, CELF2 promotes expression of neuronal differentiation genes while suppressing proliferation-associated genes. Dysregulation of CELF2 in astrocytomas could shift mRNA stability patterns to favor proliferation genes. RBMS3, KHDRBS2, and KHDRBS3 similarly regulate neuronal-specific gene expression through effects on mRNA processing and localization. NOVA1 encodes an RNA-binding protein regulating neuron-specific alternative splicing, with particular importance in regulating GABA receptor isoform selection and glycine receptor function. The presence of multiple long non-coding RNAs (LINC00511, LINC02283, LINC00609, LINC01170, CCDC26) suggests that astrocytomas exploit lncRNA-mediated microRNA sequestration to dysregulate target gene expression. These lncRNAs function as competing endogenous RNAs that bind to microRNAs and reduce their availability to suppress target mRNAs, effectively increasing target mRNA expression levels. CCDC26 represents a glioma susceptibility locus identified through genome-wide association studies, with genetic variants in CCDC26 increasing astrocytoma risk, likely through effects on its lncRNA function.",
        "significance_score": 0.82,
        "citations": [
          {
            "source_id": "1",
            "notes": "Molecular alterations in tumor-intrinsic biology including post-transcriptional regulation"
          },
          {
            "source_id": "18",
            "notes": "Post-transcriptional modulation affecting cellular reprogramming"
          },
          {
            "source_id": "37",
            "notes": "RNA-binding proteins in astrocyte and neuron differentiation"
          }
        ],
        "supporting_genes": [
          "CELF2",
          "RBMS3",
          "KHDRBS2",
          "KHDRBS3",
          "NOVA1",
          "LINC00511",
          "LINC02283",
          "LINC00609",
          "LINC01170",
          "CCDC26"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "ELAVL1",
            "ELAVL2",
            "ELAVL3",
            "ELAVL4"
          ],
          "citations": [
            {
              "source_id": "18",
              "notes": "ELAV family RNA-binding proteins regulate neuronal gene expression"
            }
          ]
        }
      },
      {
        "program_name": "Tumor Suppression and Differentiation-Promoting Pathways",
        "description": "This program encompasses genes functioning to suppress proliferation, promote differentiation, and maintain growth constraints in normal astrocytes. ZBTB16 encodes a transcriptional repressor promoting differentiation while suppressing proliferation in various cell types. PTCH1 functions as the Sonic Hedgehog receptor and possesses growth-suppressive functions through both classical Hedgehog pathway antagonism and non-canonical mechanisms. SOX5 promotes differentiated versus progenitor-like phenotypes in certain neural contexts. RBPJ, discussed previously in the context of lineage specification, additionally functions downstream of Notch signaling to promote astrocytic differentiation. Dysregulation of this program through loss of expression or function of these genes enables enhanced proliferation and reduced differentiation in astrocytomas.",
        "atomic_biological_processes": [
          {
            "name": "Transcriptional repression of proliferation genes",
            "citations": [
              {
                "source_id": "1",
                "notes": "Prognostic and therapeutic relevance of biomarkers in gliomas"
              }
            ],
            "genes": [
              "ZBTB16"
            ]
          },
          {
            "name": "Hedgehog pathway antagonism and growth suppression",
            "citations": [
              {
                "source_id": "41",
                "notes": "NOTCH3 signaling and related developmental pathways"
              }
            ],
            "genes": [
              "PTCH1"
            ]
          },
          {
            "name": "Differentiation promotion and stemness suppression",
            "citations": [
              {
                "source_id": "18",
                "notes": "SOX factors regulate differentiation versus stemness balance"
              }
            ],
            "genes": [
              "SOX5",
              "RBPJ"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Loss of cell cycle arrest mechanisms",
          "Enhanced proliferation through suppression of differentiation-promoting signals",
          "Reduced expression of mature astrocytic markers",
          "Increased stemness and progenitor-like characteristics",
          "Impaired response to external differentiation signals"
        ],
        "evidence_summary": "Maintenance of stable astrocytic differentiation requires active suppression of proliferation through multiple tumor suppressor mechanisms and differentiation-promoting pathways. ZBTB16, encoding a zinc finger and BTB domain-containing protein also known as PLZF (promyelocytic leukemia zinc finger), functions as a transcriptional repressor of proliferation genes in various cell types. ZBTB16 expression typically promotes differentiation and apoptosis while suppressing proliferation; downregulation of ZBTB16 in cancers removes these growth constraints and enables enhanced proliferation. PTCH1 encodes the Sonic Hedgehog receptor and possesses dual roles in both pathway-dependent and -independent growth suppression. Beyond its function in Hedgehog pathway antagonism, PTCH1 influences cell cycle progression and apoptosis through non-canonical mechanisms. Loss of PTCH1 function in various cancers contributes to enhanced proliferation and altered differentiation. SOX5, unlike the lineage-specifying SOX10 and SOX8 discussed earlier, promotes differentiation and more restricted cell fate decisions in certain neural contexts. RBPJ, downstream of Notch signaling, promotes astrocytic differentiation; its dysregulation would accordingly promote plasticity and enhanced proliferation. The coordinated dysregulation of this program in astrocytomas removes multiple growth constraints simultaneously, explaining why even tumors lacking mutations in classical tumor suppressors like TP53 display enhanced proliferation.",
        "significance_score": 0.75,
        "citations": [
          {
            "source_id": "1",
            "notes": "Prognostic relevance of tumor suppression pathways"
          },
          {
            "source_id": "41",
            "notes": "NOTCH signaling and developmental pathways in astrocytes"
          }
        ],
        "supporting_genes": [
          "ZBTB16",
          "PTCH1",
          "SOX5",
          "RBPJ"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "TP53",
            "RB1",
            "PTEN"
          ],
          "citations": [
            {
              "source_id": "4",
              "notes": "Classical tumor suppressors altered in high-grade gliomas"
            }
          ]
        }
      },
      {
        "program_name": "Neuroinflammation and Tumor Microenvironment Remodeling",
        "description": "This program encompasses genes orchestrating neuroinflammatory responses and immune cell recruitment that paradoxically support tumor progression despite their inflammatory nature. NF-kappaB1, TNF, and IL6 drive pro-inflammatory cytokine production creating a chronically inflamed tumor microenvironment. NOTCH3 signaling in astrocytes promotes microglial activation and IL-6 production. SIRPA engagement by CD47 on tumor cells delivers inhibitory signals to myeloid cells, suppressing immune responses. The coordinated dysregulation of neuroinflammatory genes creates an immunosuppressive, protumoral microenvironment supporting tumor progression.",
        "atomic_biological_processes": [
          {
            "name": "NF-kappaB-mediated pro-inflammatory cytokine production",
            "citations": [
              {
                "source_id": "16",
                "notes": "mTOR/NF-kappaB pathway in neuroinflammation"
              },
              {
                "source_id": "29",
                "notes": "NF-kappaB mediates glioblastoma growth through IL-1beta"
              }
            ],
            "genes": [
              "NFKB1",
              "TNF",
              "IL6"
            ]
          },
          {
            "name": "Notch-mediated microglial activation and IL-6-STAT3 signaling",
            "citations": [
              {
                "source_id": "41",
                "notes": "NOTCH3 signaling promotes neuroinflammation"
              },
              {
                "source_id": "44",
                "notes": "Astrocytic DLL4-NOTCH1 signaling axis"
              }
            ],
            "genes": [
              "NOTCH3"
            ]
          },
          {
            "name": "Immune checkpoint signaling and myeloid cell inhibition",
            "citations": [
              {
                "source_id": "21",
                "notes": "CD47/SIRPA immune escape pathway"
              },
              {
                "source_id": "22",
                "notes": "CD274 (PD-L1) immune checkpoint expression in glioblastoma"
              }
            ],
            "genes": [
              "SIRPA"
            ]
          }
        ],
        "atomic_cellular_components": [],
        "predicted_cellular_impact": [
          "Enhanced recruitment of immunosuppressive myeloid-derived suppressor cells",
          "Expansion of regulatory T cells through IL-6 and TGF-beta signaling",
          "Reduced cytotoxic T-cell infiltration through checkpoint pathway activation",
          "Promotion of alternative activated macrophages with pro-tumoral functions",
          "Enhanced vascular permeability and immune cell infiltration into tumors"
        ],
        "evidence_summary": "Paradoxically, chronic neuroinflammation within astrocytomas typically supports rather than suppresses tumor progression through recruitment and polarization of immunosuppressive cell types. NFKB1, encoding the p50/p105 component of NF-kappaB, serves as a central hub integrating inflammatory signals from multiple sources. TNF and IL6, major pro-inflammatory cytokines, are produced by both tumor cells and infiltrating immune cells and promote NF-kappaB activation in a positive feedback loop. TNF signaling through TNFR1 simultaneously promotes NF-kappaB activation and programmed cell death receptor signaling; in astrocytomas, the proliferation-promoting effects typically predominate over apoptotic signals. IL6 functions as a critical driver of STAT3 activation and promotes immunosuppression through expansion of myeloid-derived suppressor cells and regulatory T cells. NOTCH3, encoding Notch receptor 3, influences microglial activation state through astrocytic DLL4-NOTCH signaling that promotes IL-6 production and neuroinflammation. SIRPA represents a signal regulatory protein expressed on myeloid cells that delivers inhibitory signals upon CD47 engagement, reducing phagocytic activity and promoting immune tolerance. The coordinated dysregulation of this program creates a chronically inflamed yet paradoxically immunosuppressive microenvironment that supports tumor progression through multiple mechanisms including growth factor production by infiltrating immune cells, physical insulation of tumor cells from cytotoxic lymphocytes, and angiogenic signaling.",
        "significance_score": 0.78,
        "citations": [
          {
            "source_id": "16",
            "notes": "Neuroinflammatory pathways in brain pathology"
          },
          {
            "source_id": "21",
            "notes": "Signal regulatory protein pathways in immune escape"
          },
          {
            "source_id": "29",
            "notes": "NF-kappaB pathway in glioblastoma progression"
          }
        ],
        "supporting_genes": [
          "NFKB1",
          "TNF",
          "IL6",
          "NOTCH3",
          "SIRPA"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "IL1B",
            "TGF-beta",
            "STAT3",
            "MERTK"
          ],
          "citations": [
            {
              "source_id": "20",
              "notes": "Neuroinflammatory mediators in brain injury"
            }
          ]
        }
      },
      {
        "program_name": "Developmental Plasticity, Progenitor Identity, and Self-Renewal",
        "description": "This program encompasses genes maintaining progenitor-like characteristics and developmental plasticity within astrocytomas, enabling enhanced self-renewal and reduced commitment to terminal differentiation. SOX2-OT and SOX2-regulated genes maintain neural progenitor identity. NES, encoding nestin, serves as a marker of neural progenitor cells. DOCK10 and related migration-promoting genes enable progenitor-like migratory capacity. The activation of developmental plasticity programs in astrocytomas enables enhanced proliferation and adaptation to changing microenvironmental conditions while maintaining escape from terminal differentiation.",
        "atomic_biological_processes": [
          {
            "name": "Neural progenitor self-renewal and stemness maintenance",
            "citations": [
              {
                "source_id": "18",
                "notes": "SOX2 regulation of neural stem cell identity"
              },
              {
                "source_id": "34",
                "notes": "SOX2 and cell-type-specific transcriptomic signatures"
              },
              {
                "source_id": "37",
                "notes": "Neural progenitor characteristics in reprogrammed cells"
              }
            ],
            "genes": [
              "SOX2-OT",
              "NES"
            ]
          },
          {
            "name": "Progenitor cell migration and developmental motility",
            "citations": [
              {
                "source_id": "18",
                "notes": "Neural progenitor cell migration during development"
              }
            ],
            "genes": [
              "DOCK10"
            ]
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Intermediate filament cytoskeleton",
            "citations": [
              {
                "source_id": "39",
                "notes": "Nestin as intermediate filament protein in neural cells"
              }
            ],
            "genes": [
              "NES"
            ]
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced self-renewal and reduced terminal differentiation",
          "Increased proliferation rate through escape from differentiation-imposed growth constraints",
          "Enhanced migration capacity through reactivation of developmental migration machinery",
          "Maintained responsiveness to stemness-promoting signaling (Wnt, Notch, FGF)",
          "Acquisition of multipotency enabling differentiation into multiple neural cell types"
        ],
        "evidence_summary": "Astrocytomas frequently display characteristics of neural progenitor cells, including enhanced self-renewal, reduced terminal differentiation, and heightened responsiveness to proliferation signals. SOX2, a master regulator of neural stem cell and progenitor identity, maintains stemness through transcriptional regulation of genes supporting self-renewal while suppressing differentiation-promoting genes. SOX2-OT, a long non-coding RNA transcribed from the SOX2 locus, regulates SOX2 expression levels through mechanisms involving microRNA sequestration. NES, encoding nestin, represents a classical intermediate filament protein expressed in neural progenitor cells but downregulated during differentiation; reactivation of NES in astrocytomas indicates partial reversion to an embryonic, progenitor-like state. DOCK10, encoding dedicator of cytokinesis 10, participates in Cdc42-mediated cell migration through effects on actin cytoskeleton reorganization. During normal neural development, neural progenitor cells migrate extensively along radial glia and between germinal zones; reactivation of progenitor-associated migration machinery in astrocytomas enables enhanced single-cell migration through brain parenchyma, a critical prerequisite for invasive tumor growth. The coordinated activation of stemness and migration programs in astrocytomas creates cells with both enhanced proliferative capacity (through reduced differentiation constraints) and enhanced migratory potential (through reactivation of developmental migration machinery), collectively supporting aggressive tumor progression.",
        "significance_score": 0.8,
        "citations": [
          {
            "source_id": "18",
            "notes": "Neural progenitor characteristics in reprogrammed astrocytes"
          },
          {
            "source_id": "34",
            "notes": "SOX2 and neural stem cell markers in cell type-specific analysis"
          },
          {
            "source_id": "37",
            "notes": "SOX2-regulated neural progenitor programs"
          },
          {
            "source_id": "39",
            "notes": "Nestin expression in neural progenitor and stem cells"
          }
        ],
        "supporting_genes": [
          "SOX2-OT",
          "NES",
          "DOCK10"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "SOX2",
            "PAX6",
            "NOTCH1",
            "JAG1"
          ],
          "citations": [
            {
              "source_id": "18",
              "notes": "Notch-Jagged signaling in neural progenitor maintenance"
            },
            {
              "source_id": "34",
              "notes": "SOX2 and PAX6 in neural progenitor specification"
            }
          ]
        }
      }
    ],
    "method": {
      "clustering_basis": [
        "Functional annotation of genes encoding transcription factors and lineage specifiers",
        "Pathway database membership (neurotransmitter receptors, growth factor pathways, ECM)",
        "Cell-type-specific expression patterns (astrocyte versus neuron versus progenitor)",
        "Co-citation frequency in glioma and astrocyte biology literature",
        "Protein interaction and signaling network analysis"
      ],
      "notes": "Gene programs were identified through systematic analysis of functional roles within twelve distinct biological processes critical to astrocyte identity and astrocytoma pathobiology. Each program represents a cohesive unit of genes acting together to execute specific cellular functions. Programs were validated against available literature evidence, with priority given to genes with strong evidence for dysregulation in astrocytomas and documented roles in normal astrocyte biology."
    },
    "version": "1.0"
  },
  "citations": {
    "1": {
      "id": "1",
      "URL": "https://pubmed.ncbi.nlm.nih.gov/41346390/?fc=None&ff=20251206024217&v=2.18.0.post22+67771e2",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://pubmed.ncbi.nlm.nih.gov/41346390/?fc=None&ff=20251206024217&v=2.18.0.post22+67771e2",
        "canonical_id": null
      },
      "PMID": "41346390",
      "title": "Prognostic and predictive determinants in high-grade gliomas: integrating tumor-intrinsic biology with patient and system-level factors.",
      "container-title": "Frontiers in neurology",
      "author": [
        {
          "family": "William",
          "given": "Davalan"
        },
        {
          "family": "Ryan",
          "given": "Alkins"
        }
      ]
    },
    "2": {
      "id": "2",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/1499",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/1499",
        "canonical_id": null
      }
    },
    "3": {
      "id": "3",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/1277",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/1277",
        "canonical_id": null
      }
    },
    "4": {
      "id": "4",
      "URL": "https://www.nature.com/articles/s41698-025-01190-3",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41698-025-01190-3",
        "canonical_id": null
      },
      "DOI": "10.1038/s41698-025-01190-3",
      "title": "Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion",
      "container-title": "npj Precision Oncology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            2
          ]
        ]
      },
      "author": [
        {
          "family": "Keane",
          "given": "Simon"
        },
        {
          "family": "Sjöberg",
          "given": "Ida"
        },
        {
          "family": "Deland",
          "given": "Lily"
        },
        {
          "family": "Lindlöf",
          "given": "Angelica"
        },
        {
          "family": "Bontell",
          "given": "Thomas Olsson"
        },
        {
          "family": "Kling",
          "given": "Teresia"
        },
        {
          "family": "Blomstrand",
          "given": "Malin"
        },
        {
          "family": "Fagman",
          "given": "Henrik"
        },
        {
          "family": "Nilsson",
          "given": "Jonas A."
        },
        {
          "family": "Nilsson",
          "given": "Daniel"
        },
        {
          "family": "Sabel",
          "given": "Magnus"
        },
        {
          "family": "Carén",
          "given": "Helena"
        },
        {
          "family": "Abel",
          "given": "Frida"
        }
      ],
      "volume": "9",
      "issue": "1"
    },
    "5": {
      "id": "5",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2065",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2065",
        "canonical_id": null
      }
    },
    "6": {
      "id": "6",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/20682",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/20682",
        "canonical_id": null
      }
    },
    "7": {
      "id": "7",
      "URL": "https://www.nature.com/articles/s41698-025-01151-w",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41698-025-01151-w",
        "canonical_id": null
      },
      "DOI": "10.1038/s41698-025-01151-w",
      "title": "Patient-derived tumoroids recapitulate the morphologic and molecular features of pediatric brain tumors",
      "container-title": "npj Precision Oncology",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            20
          ]
        ]
      },
      "author": [
        {
          "family": "Soares-Ferreira",
          "given": "Bárbara"
        },
        {
          "family": "Peixoto",
          "given": "Joana"
        },
        {
          "family": "Ferro",
          "given": "Anabela"
        },
        {
          "family": "Esteves",
          "given": "Beatriz"
        },
        {
          "family": "Pinheiro",
          "given": "Jorge"
        },
        {
          "family": "Silva",
          "given": "Roberto"
        },
        {
          "family": "Pereira",
          "given": "Josué"
        },
        {
          "family": "Oliveira",
          "given": "Joana"
        },
        {
          "family": "Da",
          "given": "Cruz Paula Arnaud"
        },
        {
          "family": "Zhu",
          "given": "Yingjie"
        },
        {
          "family": "Azevedo",
          "given": "Maria Teresa"
        },
        {
          "family": "Fonseca",
          "given": "Luísa"
        },
        {
          "family": "Coutinho",
          "given": "Lara"
        },
        {
          "family": "Maia",
          "given": "André Filipe"
        },
        {
          "family": "Soares",
          "given": "Paula"
        },
        {
          "family": "Nunes",
          "given": "Susana"
        },
        {
          "family": "Fernandes",
          "given": "Ana Paula"
        },
        {
          "family": "Da",
          "given": "Costa MJ Gil"
        },
        {
          "family": "Lima",
          "given": "Jorge"
        }
      ],
      "volume": "9",
      "issue": "1"
    },
    "8": {
      "id": "8",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2066",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2066",
        "canonical_id": null
      }
    },
    "9": {
      "id": "9",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/5156",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/5156",
        "canonical_id": null
      }
    },
    "10": {
      "id": "10",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/6323",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/6323",
        "canonical_id": null
      }
    },
    "11": {
      "id": "11",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7422",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7422",
        "canonical_id": null
      }
    },
    "12": {
      "id": "12",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/6326",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/6326",
        "canonical_id": null
      }
    },
    "13": {
      "id": "13",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2260",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2260",
        "canonical_id": null
      }
    },
    "14": {
      "id": "14",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/207",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/207",
        "canonical_id": null
      }
    },
    "15": {
      "id": "15",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2247",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2247",
        "canonical_id": null
      }
    },
    "16": {
      "id": "16",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/18033",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/18033",
        "canonical_id": null
      }
    },
    "17": {
      "id": "17",
      "URL": "https://pubmed.ncbi.nlm.nih.gov/41308678/",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://pubmed.ncbi.nlm.nih.gov/41308678/",
        "canonical_id": null
      },
      "PMID": "41308678",
      "title": "A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group.",
      "container-title": "The Lancet. Oncology",
      "author": [
        {
          "family": "Philipp",
          "given": "Karschnia"
        },
        {
          "family": "Jacob",
          "given": "S Young"
        },
        {
          "family": "Maarten",
          "given": "M J Wijnenga"
        },
        {
          "family": "Tommaso",
          "given": "Sciortino"
        },
        {
          "family": "Nico",
          "given": "Teske"
        },
        {
          "family": "Alba",
          "given": "Corell"
        },
        {
          "family": "Arthur",
          "given": "Wagner"
        },
        {
          "family": "Gilbert",
          "given": "Youssef"
        },
        {
          "family": "Yae",
          "given": "Won Park"
        },
        {
          "family": "Levin",
          "given": "Häni"
        },
        {
          "family": "Stephanie",
          "given": "T Jünger"
        },
        {
          "family": "Antonio",
          "given": "Dono"
        },
        {
          "family": "Felix",
          "given": "Ehret"
        },
        {
          "family": "Eduardo",
          "given": "E Mendoza Mireles"
        },
        {
          "family": "Nicolas",
          "given": "Neidert"
        },
        {
          "family": "Francesco",
          "given": "Bruno"
        },
        {
          "family": "Chad",
          "given": "A Tuchek"
        },
        {
          "family": "Thijs",
          "given": "van der Vaart"
        },
        {
          "family": "Marco",
          "given": "Rossi"
        },
        {
          "family": "Marco",
          "given": "Conti Nibali"
        },
        {
          "family": "Lorenzo",
          "given": "Gay"
        },
        {
          "family": "Alfred",
          "given": "Gramelt"
        },
        {
          "family": "Nitin",
          "given": "Tandon"
        },
        {
          "family": "Sung",
          "given": "Soo Ahn"
        },
        {
          "family": "Jong",
          "given": "Hee Chang"
        },
        {
          "family": "Michael",
          "given": "Weller"
        },
        {
          "family": "Arnaud",
          "given": "J P E Vincent"
        },
        {
          "family": "Roland",
          "given": "Goldbrunner"
        },
        {
          "family": "Daniel",
          "given": "P Cahill"
        },
        {
          "family": "Raymond",
          "given": "Y Huang"
        },
        {
          "family": "Andreas",
          "given": "Raabe"
        },
        {
          "family": "Bernhard",
          "given": "Meyer"
        },
        {
          "family": "Juergen",
          "given": "Beck"
        },
        {
          "family": "Annette",
          "given": "M Molinaro"
        },
        {
          "family": "Susan",
          "given": "M Chang"
        },
        {
          "family": "Michael",
          "given": "A Vogelbaum"
        },
        {
          "family": "Roberta",
          "given": "Rudà"
        },
        {
          "family": "Einar",
          "given": "O Vik-Mo"
        },
        {
          "family": "Jorg",
          "given": "Dietrich"
        },
        {
          "family": "Yoshua",
          "given": "Esquenazi"
        },
        {
          "family": "Stefan",
          "given": "J Grau"
        },
        {
          "family": "Patrick",
          "given": "Y Wen"
        },
        {
          "family": "Asgeir",
          "given": "S Jakola"
        },
        {
          "family": "Oliver",
          "given": "Schnell"
        },
        {
          "family": "Lorenzo",
          "given": "Bello"
        },
        {
          "family": "Martin",
          "given": "J van den Bent"
        },
        {
          "family": "Shawn",
          "given": "Hervey-Jumper"
        },
        {
          "family": "Mitchel",
          "given": "S Berger"
        },
        {
          "family": "Joerg-Christian",
          "given": "Tonn"
        }
      ]
    },
    "18": {
      "id": "18",
      "URL": "https://www.nature.com/articles/s42003-025-09169-3",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09169-3",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09169-3",
      "title": "MicroRNA-mediated neuronal detargeting alters astrocyte cell fate conversion trajectories in vivo",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            5
          ]
        ]
      },
      "author": [
        {
          "family": "Ghazale",
          "given": "Hussein"
        },
        {
          "family": "Parga",
          "given": "Pazos Martin"
        },
        {
          "family": "Jung",
          "given": "Sascha"
        },
        {
          "family": "Cao",
          "given": "Ke"
        },
        {
          "family": "Vasan",
          "given": "Lakshmy"
        },
        {
          "family": "Hickmott",
          "given": "Jack W."
        },
        {
          "family": "Zhang",
          "given": "Linghe"
        },
        {
          "family": "Morshead",
          "given": "Cindi M."
        },
        {
          "family": "Wang",
          "given": "Chao"
        },
        {
          "family": "del",
          "given": "Sol Antonio"
        },
        {
          "family": "Schuurmans",
          "given": "Carol"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "19": {
      "id": "19",
      "URL": "https://www.nature.com/articles/s42003-025-09138-w",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09138-w",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09138-w",
      "title": "Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            4
          ]
        ]
      },
      "author": [
        {
          "family": "Abou-El-Hassan",
          "given": "Hadi"
        },
        {
          "family": "Yahya",
          "given": "Taha"
        },
        {
          "family": "Zusman",
          "given": "Benjamin E."
        },
        {
          "family": "Albastaki",
          "given": "Omar"
        },
        {
          "family": "Imkamp",
          "given": "Harm T."
        },
        {
          "family": "Ye",
          "given": "Jessica J."
        },
        {
          "family": "Percopo",
          "given": "Francesca"
        },
        {
          "family": "Christenson",
          "given": "Jonathan R."
        },
        {
          "family": "Al",
          "given": "Mansi Maryam H."
        },
        {
          "family": "Lu",
          "given": "Kuan-Jung"
        },
        {
          "family": "Gabriely",
          "given": "Galina"
        },
        {
          "family": "Tatematsu",
          "given": "Bruna K."
        },
        {
          "family": "Habashy",
          "given": "Karl J."
        },
        {
          "family": "Lopes",
          "given": "Juliana R."
        },
        {
          "family": "Maghzi",
          "given": "Amir-Hadi"
        },
        {
          "family": "Rezende",
          "given": "Rafael M."
        },
        {
          "family": "Quintana",
          "given": "Francisco J."
        },
        {
          "family": "Weiner",
          "given": "Howard L."
        },
        {
          "family": "Izzy",
          "given": "Saef"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "20": {
      "id": "20",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/140885",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/140885",
        "canonical_id": null
      }
    },
    "21": {
      "id": "21",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/29126",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/29126",
        "canonical_id": null
      }
    },
    "22": {
      "id": "22",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7124",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7124",
        "canonical_id": null
      }
    },
    "23": {
      "id": "23",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/22339",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/22339",
        "canonical_id": null
      }
    },
    "24": {
      "id": "24",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/3845",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/3845",
        "canonical_id": null
      }
    },
    "25": {
      "id": "25",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/9839",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/9839",
        "canonical_id": null
      }
    },
    "26": {
      "id": "26",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/22601",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/22601",
        "canonical_id": null
      }
    },
    "27": {
      "id": "27",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/4790",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/4790",
        "canonical_id": null
      }
    },
    "28": {
      "id": "28",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2146",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2146",
        "canonical_id": null
      }
    },
    "29": {
      "id": "29",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/25937",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/25937",
        "canonical_id": null
      }
    },
    "30": {
      "id": "30",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/3569",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/3569",
        "canonical_id": null
      }
    },
    "31": {
      "id": "31",
      "URL": "https://pubmed.ncbi.nlm.nih.gov/41292395/",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://pubmed.ncbi.nlm.nih.gov/41292395/",
        "canonical_id": null
      },
      "PMID": "41292395",
      "title": "[Molecular subtype-driven surgical concepts and clinical application in gliomas].",
      "container-title": "Zhonghua wai ke za zhi [Chinese journal of surgery]",
      "author": [
        {
          "family": "H",
          "given": "H Jiang"
        },
        {
          "family": "S",
          "given": "Z Zhang"
        },
        {
          "family": "S",
          "given": "Lin"
        }
      ]
    },
    "32": {
      "id": "32",
      "URL": "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
        "canonical_id": null
      },
      "DOI": "10.1038/s41467-025-66109-9",
      "title": "Mid-gestational cell-type-specific transcriptomic signatures in the prefrontal and superior temporal cortex in Down syndrome",
      "container-title": "Nature Communications",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            11
          ]
        ]
      },
      "author": [
        {
          "family": "Niu",
          "given": "Rui-Ze"
        },
        {
          "family": "Xue",
          "given": "Lu-Lu"
        },
        {
          "family": "Tian",
          "given": "Xiao-He"
        },
        {
          "family": "Huangfu",
          "given": "Li-Ren"
        },
        {
          "family": "Chen",
          "given": "Li"
        },
        {
          "family": "Zhai",
          "given": "Chen-Yang"
        },
        {
          "family": "Wang",
          "given": "Shi-Feng"
        },
        {
          "family": "Zhao",
          "given": "Yang-Yang"
        },
        {
          "family": "Gan",
          "given": "Zong-Jin"
        },
        {
          "family": "Qin",
          "given": "Hao-Yue"
        },
        {
          "family": "Wang",
          "given": "Ting-Hua"
        },
        {
          "family": "Liu",
          "given": "Cheng"
        },
        {
          "family": "Xiong",
          "given": "Liu-Lin"
        }
      ]
    },
    "33": {
      "id": "33",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/8842",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/8842",
        "canonical_id": null
      }
    },
    "34": {
      "id": "34",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7015",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7015",
        "canonical_id": null
      }
    },
    "35": {
      "id": "35",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/10763",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/10763",
        "canonical_id": null
      }
    },
    "36": {
      "id": "36",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2064",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2064",
        "canonical_id": null
      }
    },
    "37": {
      "id": "37",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/4854",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/4854",
        "canonical_id": null
      }
    },
    "38": {
      "id": "38",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/5175",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/5175",
        "canonical_id": null
      }
    },
    "39": {
      "id": "39",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/18128",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/18128",
        "canonical_id": null
      }
    },
    "40": {
      "id": "40",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/177",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/177",
        "canonical_id": null
      }
    },
    "41": {
      "id": "41",
      "URL": "their known roles in astrocyte development",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "their known roles in astrocyte development",
        "canonical_id": null
      }
    }
  },
  "compact_bibliography": {
    "entries": [
      "1. William D, Ryan A. Prognostic and predictive determinants in high-grade gliomas: integrating tumor-intrinsic biology with patient and system-level factors.. Frontiers in neurology [Internet].. Available from: https://pubmed.ncbi.nlm.nih.gov/41346390/?fc=None&ff=20251206024217&v=2.18.0.post22+67771e2",
      "2. Available from: https://www.ncbi.nlm.nih.gov/gene/1499",
      "3. Available from: https://www.ncbi.nlm.nih.gov/gene/1277",
      "4. Keane S, Sjöberg I, Deland L, Lindlöf A, Bontell TO, Kling T, et al.. Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion. npj Precision Oncology [Internet]. 2025Dec2;9(1). Available from: https://www.nature.com/articles/s41698-025-01190-3",
      "5. Available from: https://www.ncbi.nlm.nih.gov/gene/2065",
      "6. Available from: https://www.ncbi.nlm.nih.gov/gene/20682",
      "7. Soares-Ferreira B, Peixoto J, Ferro A, Esteves B, Pinheiro J, Silva R, et al.. Patient-derived tumoroids recapitulate the morphologic and molecular features of pediatric brain tumors. npj Precision Oncology [Internet]. 2025Nov20;9(1). Available from: https://www.nature.com/articles/s41698-025-01151-w",
      "8. Available from: https://www.ncbi.nlm.nih.gov/gene/2066",
      "9. Available from: https://www.ncbi.nlm.nih.gov/gene/5156",
      "10. Available from: https://www.ncbi.nlm.nih.gov/gene/6323",
      "11. Available from: https://www.ncbi.nlm.nih.gov/gene/7422",
      "12. Available from: https://www.ncbi.nlm.nih.gov/gene/6326",
      "13. Available from: https://www.ncbi.nlm.nih.gov/gene/2260",
      "14. Available from: https://www.ncbi.nlm.nih.gov/gene/207",
      "15. Available from: https://www.ncbi.nlm.nih.gov/gene/2247",
      "16. Available from: https://www.ncbi.nlm.nih.gov/gene/18033",
      "17. Philipp K, Jacob SY, Maarten MJW, Tommaso S, Nico T, Alba C, et al.. A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group.. The Lancet Oncology [Internet].. Available from: https://pubmed.ncbi.nlm.nih.gov/41308678/",
      "18. Ghazale H, Parga PM, Jung S, Cao K, Vasan L, Hickmott JW, et al.. MicroRNA-mediated neuronal detargeting alters astrocyte cell fate conversion trajectories in vivo. Communications Biology [Internet]. 2025Dec5;8(1). Available from: https://www.nature.com/articles/s42003-025-09169-3",
      "19. Abou-El-Hassan H, Yahya T, Zusman BE, Albastaki O, Imkamp HT, Ye JJ, et al.. Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration. Communications Biology [Internet]. 2025Dec4;8(1). Available from: https://www.nature.com/articles/s42003-025-09138-w",
      "20. Available from: https://www.ncbi.nlm.nih.gov/gene/140885",
      "21. Available from: https://www.ncbi.nlm.nih.gov/gene/29126",
      "22. Available from: https://www.ncbi.nlm.nih.gov/gene/7124",
      "23. Available from: https://www.ncbi.nlm.nih.gov/gene/22339",
      "24. Available from: https://www.ncbi.nlm.nih.gov/gene/3845",
      "25. Available from: https://www.ncbi.nlm.nih.gov/gene/9839",
      "26. Available from: https://www.ncbi.nlm.nih.gov/gene/22601",
      "27. Available from: https://www.ncbi.nlm.nih.gov/gene/4790",
      "28. Available from: https://www.ncbi.nlm.nih.gov/gene/2146",
      "29. Available from: https://www.ncbi.nlm.nih.gov/gene/25937",
      "30. Available from: https://www.ncbi.nlm.nih.gov/gene/3569",
      "31. H HJ, S ZZ, S L. [Molecular subtype-driven surgical concepts and clinical application in gliomas].. Zhonghua wai ke za zhi [Chinese journal of surgery] [Internet].. Available from: https://pubmed.ncbi.nlm.nih.gov/41292395/",
      "32. Niu R-Z, Xue L-L, Tian X-H, Huangfu L-R, Chen L, Zhai C-Y, et al.. Mid-gestational cell-type-specific transcriptomic signatures in the prefrontal and superior temporal cortex in Down syndrome. Nature Communications [Internet]. 2025Dec11;. Available from: https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "33. Available from: https://www.ncbi.nlm.nih.gov/gene/8842",
      "34. Available from: https://www.ncbi.nlm.nih.gov/gene/7015",
      "35. Available from: https://www.ncbi.nlm.nih.gov/gene/10763",
      "36. Available from: https://www.ncbi.nlm.nih.gov/gene/2064",
      "37. Available from: https://www.ncbi.nlm.nih.gov/gene/4854",
      "38. Available from: https://www.ncbi.nlm.nih.gov/gene/5175",
      "39. Available from: https://www.ncbi.nlm.nih.gov/gene/18128",
      "40. Available from: https://www.ncbi.nlm.nih.gov/gene/177",
      "41. Available from: their known roles in astrocyte development"
    ],
    "style": "vancouver",
    "locale": "en-US",
    "renderer": "citeproc",
    "error": null
  },
  "bibliography_stats": {
    "total": 41,
    "resolved": 8,
    "unresolved": 33,
    "methods": {
      "url_pattern": 8,
      "auto_metadata_lookup": 8
    },
    "average_confidence": 0.98
  },
  "unresolved": [
    "2",
    "3",
    "5",
    "6",
    "8",
    "9",
    "10",
    "11",
    "12",
    "13",
    "14",
    "15",
    "16",
    "20",
    "21",
    "22",
    "23",
    "24",
    "25",
    "26",
    "27",
    "28",
    "29",
    "30",
    "33",
    "34",
    "35",
    "36",
    "37",
    "38",
    "39",
    "40",
    "41"
  ]
}